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Abstract 
The Utilization of Evidence-Based Treatments in Trauma Treatment of Active 
Military Personnel and Their Families 
Matt Brickell 
Antioch University Seattle 
Seattle, WA 
 
This study reviewed the literature regarding the effectiveness of evidence-based 
treatments in addressing traumatic stress injuries such as post-traumatic stress disorder in 
active military personnel and their families. Top tier treatments recommended by the 
Department of Defense and Department of Veteran Affairs Clinical Practice Guidelines 
for the treatment of traumatic stress disorders are discussed, and the literature is critically 
examined with a focus on exploring the reported evidence of effectiveness. In addition, 
this study contributed unpublished archival clinical outcome data from evidence-based 
treatment of active military personnel and their families in real-world clinical settings. 
The effectiveness of an evidence-based treatment is examined utilizing the most 
consistently utilized outcome measures in the reviewed literature.  The electronic version 
of this dissertation is at OhioLink ETD Center, www.ohiolink.edu/etd 
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Chapter I: Introduction 
The Institute of Medicine (IOM, 2012) recently estimated that 2.6 million 
United States (U.S.) military personnel served in Iraq or Afghanistan since 2001. 
Among those 2.6 million individuals, the IOM found posttraumatic stress disorder 
(PTSD) prevalence rates to be between 13% and 20%; this percent represents a total 
of between 338,000 and 520,000 active duty personnel with PTSD. The PTSD 
prevalence rates for Vietnam veterans are similar to those of veterans from the Iraq 
and Afghanistan wars (Kulka et al., 1990). Specifically, the National Vietnam 
Veterans Readjustment Study (NVVRS) (Kulka et al., 1990) found that 15.2% of 
Vietnam veterans had PTSD at the time of the study and that 30.9% had PTSD at 
some point during their lifetime. Currently, PTSD is the most prevalent psychiatric 
disorder for which veterans seek disability benefits and the third most commonly 
compensated disorder (U.S. Department of Veterans Affairs, 2012). Furthermore, a 
Department of Defense (DOD) and Department of Veterans’ Affairs (VA) 
conference on veteran suicide prevention reported there are approximately 18 U.S. 
veteran suicides each day. Additionally, the suicide rates in the U.S. Army nearly 
doubled from 2004 to 2008 (Sayer, Carlson, & Frazier, 2014). Most service 
members who committed suicide were not receiving any mental health treatment at 
the time of their death (Shinsheki, 2010). According to the IOM (2012), “effective 
treatments for PTSD may reduce the risk for suicide and psychiatric hospitalization 
in those who have PTSD” (p. 317). 
Bradley, Greene, Russ, Dutra, and Westen (2005) conducted a meta-analysis 
of psychotherapies for PTSD, reviewing randomized controlled trial (RCT) studies 
2 
published between 1980 and 2003. The psychotherapies studied included: Exposure 
Therapy (ET), Cognitive Behavioral Therapy (CBT), ET plus CBT, and Eye 
Movement Desensitization and Reprocessing (EMDR). Of the 26 studies reviewed, 
40% failed to report data regarding the completion rates of participants. Among 
studies including the completion rate, the results differed according to treatment 
modality: ET studies averaged a 75.9% completion rate; CBT averaged an 82.8% 
completion rate, ET plus CBT averaged a 67% completion rate, and EMDR 
averaged an 88.7% completion rate. Bradley et al. found that across the studies 
reviewed, the completion rate was negatively associated with at least one outcome 
measure; therefore, it is possible that the patients who did not get better dropped out 
of the RCT studies, thereby influencing reported improvement rates. As a result, it 
was recommended that future research on PTSD psychotherapies be conducted 
without controls in real-world clinical settings (Bradley et al., 2005). 
PTSD Treatment Guidelines 
The Department of Veterans’ Affairs and the Department of Defense (VA & 
DOD) published the first clinical guidelines for the treatment of PTSD in 2004. The 
VA and DOD guidelines noted that PTSD was the most common mental disorder 
resulting from combat, and the stated goal of the guidelines was, “to aid field 
personnel and health care workers in identifying, assessing, and/or treating military 
men and women and veterans who have survived traumatic events” (p. i). Focusing 
on the prevention, assessment, and treatment of a range of traumatic disorders, the 
VA and DOD guidelines strongly recommend four specific psychotherapy 
treatments for PTSD: Cognitive Therapy (CT), ET, Stress Inoculation Training 
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(SIT), and EMDR. Shortly thereafter, the American Psychiatric Association 
(American Psychiatric Association, 2004) published their own clinical treatment 
guidelines for PTSD, essentially highlighting the same psychotherapeutic 
interventions as the VA and DOD (2004) guidelines. Drawing similar conclusions to 
those contained in the VA and DOD guidelines, the American Psychiatric 
Association (2004) guidelines recommended the same four psychotherapy 
treatments. 
The VA and DOD (2010) revised their guidelines six years later, and shifted 
away from recommending specific treatments. Rather, the VA and DOD (2010) 
guidelines discussed evidence-based trauma-focused treatments, and the common 
elements of those treatments.  The VA and DOD (2010) guidelines noted that 
trauma-focused treatments use a broad range of interventions based on a number of 
theories and models, including: learning theory, cognitive theory, emotional 
processing theory, fear-conditioning models, and others (p. 115). The most common 
elements of those treatments include exposure and/or cognitive restructuring 
combined with anxiety management and stress reduction skills. The 
recommendations of the VA and DOD (2010) guidelines are based on RCTs and 
meta-analyses of trauma-focused treatments; however, despite the target populations 
of the VA and DOD, many of these RCTs are not conducted with veterans or active 
military populations.  
Determining Evidence-Based PTSD Psychotherapies  
While many, including the American Psychological Association, have 
advocated for the use of both efficacy and effectiveness studies as methods of 
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validating treatments (American Psychological Association, 1995; Barlow, 1996; 
Hoagwood, Hibbs, Brent, & Jensen, 1995), there is still a lack of consistent criteria 
in the literature for the determination of a psychotherapy treatment as an 
evidence-based treatment (Kazdin, 2008, 2011). The American Psychological 
Association Task Force (1995) offered a template for creating guidelines to evaluate 
psychotherapy along two conditions: internal validity (efficacy) and clinical utility 
(effectiveness). 
Efficacy standards. The American Psychological Association’s (1995) clinical 
research guidelines recommended evaluating efficacy through rigorous scientific research 
designed to assess the impact of psychological interventions, primarily in a controlled 
clinical research setting. According to the template, the efficacy of a psychological 
intervention was demonstrated through RCTs comparing that intervention to other 
treatment conditions (alternative therapy, non-specific therapy, or no therapy). This type 
of evidence informed the basis of most clinical practice guidelines (Barlow, 1996). 
Members of the American Psychological Association Task Force, Chambless 
and Hollon (1998), noted the American Psychological Association (1995) 
recommended that guidelines for treatment interventions be evaluated with respect 
to how closely they adhere to empirical evidence. Chambless and Hollon attempted 
to clarify this definition by broadening criteria slightly; according to the Chambless 
and Hollon criteria, as well as the American Psychological Association (1995) 
criteria, the efficacy of a treatment is best demonstrated by RCTs and independent 
replication. Other proposed criteria regarding the methodological evaluation of 
psychotherapy research studies exist throughout the literature. Foa and Meadows 
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(1997) suggested a Gold Standard (GS) of seven criteria, specifically for evaluating 
the efficacy of EMDR studies: (a) clearly defined target symptoms; (b) reliable and 
valid measures; (c) use of blind evaluators; (d) information about an assessor’s 
training; (e) manualized, replicable, specific treatment; (f) unbiased treatment; and 
(g) treatment adherence. Although Foa and Meadows originally targeted EMDR 
studies specifically, their criteria are applicable to the evaluation of most 
evidence-based treatment (EBT) research studies. 
Further revising the GS established by Foa and Meadows (1997), Maxfield and 
Hyer (2002) created the Revised Gold Standard (RGS) through the introduction of three 
additional guidelines for methodological evaluation of EMDR research: a) no confounded 
conditions; (b) use of multi-modal measures; and (c) length of treatment for participants. 
Maxfield and Hyer noted that confounded treatment conditions increase the likelihood of 
Type II error and decrease construct validity. In addition, the accuracy of evaluations is 
assumed to increase through multimodal measures compared to evaluation through 
self-report alone. The length of treatment was modified to introduce a satisfactory course 
of treatment out of the concern that multiple-trauma clients typically required more 
extensive treatment. The resulting guidelines included 10 total criteria; again, although 
these guidelines were established for the evaluation of EMDR research, they are 
applicable to most EBT research studies. 
Building upon standards identified by Maxfield and Hyer (2002) as well as Foa 
and Meadows (1997), Hertlein and Ricci (2004) developed a Platinum Standard (PS) for 
evaluating the methodological characteristics of EMDR research studies. Hertlein and 
Ricci introduced three new criterions, resulting in 13 total criteria for the guidelines. The 
6 
additions included: a criterion accounting for therapist training level; evidence of a 
control group or comparison group; and the inclusion of effect size in accordance with 
American Psychological Association recommendations. While the standards developed 
by Hertlein and Ricci were targeted towards EMDR research studies, they are applicable 
to most of the research studies conducted on the EBTs endorsed by the VA and DOD 
(2010) treatment guidelines. 
In a meta-analysis of PTSD psychotherapies, Bradley et al. (2005) suggested 
that the prevalent utilization of waitlist and inert control conditions was highly 
problematic, since these conditions fail to address the common factors that threaten 
internal validity. For example, the two most common control conditions besides wait 
list were relaxation therapy and supportive psychotherapy; neither of these was 
intended or expected to succeed (p. 226). Furthermore, these conditions do not 
control for the confounding variables of clinician commitment and allegiance 
effects. As a result, Bradley et al. recommended that the best method for convincing 
experienced clinicians to make greater use of therapies researched by RCTs in 
laboratory settings would be to publish effectiveness research. Specifically, Bradley 
et al. (2005) called for research without “any form of controls other than genuine 
therapies with committed therapists, preferably treatments as practiced in the 
community, working with samples of patients resembling those seen in the 
community” (p. 226). Bradley et al.’s conclusion highlighted the gap in the literature 
between efficacy and effectiveness research, and echoed the American 
Psychological Association (1995) definition of efficacy as a measure of internal 
validity. For the purposes of this study, the efficacy of treatment will be determined 
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by the existence of research and RCTs that answer the question, “Does treatment 
work?” (Kazdin, 2008, p. 151). 
Effectiveness standards. The American Psychological Association’s (1995) 
clinical research guidelines suggested assessing effectiveness by considering the 
clinical utility and feasibility of an intervention in the local setting where that 
intervention is delivered. In addition, the American Psychological Association 
recommended evaluating the generalizability of interventions with established 
efficacy. The American Psychological Association guidelines adopted the position 
that a combination of both efficacy and effectiveness studies is preferred for 
validating psychotherapy treatment. The template for constructing psychological 
intervention guidelines provided by the American Psychological Association 
emphasized the external validity of effectiveness studies, and highlighted their 
appropriateness for assessing feasibility of treatment, generalizability of treatment, 
as well as the costs and benefits of treatment (Barlow, 1996; Chambless & Hollon, 
1998); however, despite this position, there is no consensus in the literature 
regarding the standards for effectiveness studies (Barlow, 1996; Seligman, 1995). 
Barlow (1996) noted that effectiveness studies and clinical utility studies are often 
synonymous in the research. Similarly, De Maat, Dekker, Schoevers, and Jonghe (2007) 
stated that effectiveness research is often characterized as outcome research, rather than 
process research. Furthermore, De Maat et al. reported consensus in the field that 
empirical research, “can and must be ordered in a hierarchical system” (p. 59); the Centre 
for Evidence-Based Medicine Oxford (2009) published a widely accepted hierarchy: 
1a. A systematic review of several RCTs with homogenous results 
8 
1b. One individual high-quality RCT 
1c. One individual all-or-none study 
2a. A systematic review of cohort studies or of patient-control studies with 
homogenous results  
2b. One individual cohort study or one individual lower quality RCT 
2c. Outcome research/Effectiveness Study 
3a. A systematic review of case-control studies with homogenous results 
3b. One individual case-control study 
4. Case series or a lower quality cohort study
5. Expert’s opinions or generally accepted therapeutic methods
While such a hierarchy is useful for developing a relative ordering of research, it does not 
discuss specific standards for effectiveness research. The differences between high- and 
low-quality RCTs are explored, but effectiveness studies are not standardized. The lack 
of a clear model for effectiveness studies represents a gap in the literature.  
Kazdin (2008, 2011) noted frequently inconsistent criteria in the literature 
determining if a treatment should be considered evidence-based; however, Kazdin 
(2008, 2011) found one reoccurring element: the researched treatment must produce 
a measured outcome different from the outcome of a control, usually either a 
no-treatment control or treatment-as-usual condition. Kazdin (2011) reported this 
criterion as primarily established in the literature through RCTs, and the American 
Psychological Association (1995) task force specifically favored RCTs as a means 
of determining the evidence-base for treatment; however, most RCTs are not 
evaluated through systematic real-world application with clients in order to 
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determine whether or not they influence change (Kazdin, 2011). In order to further 
clarify the meaning and intent of effectiveness research, real-world, practical, or 
actual clinical settings are defined as locations that typically offer treatment, rather 
than clinics or sites dedicated to research (Kazdin, 2011). 
In addition, Kazdin (2008) stated that while this criterion necessitates the 
demonstration of statistically significant differences between the groups after 
treatment, any measured statistical significance does not automatically translate into 
improved real world functioning of the patients. Similarly, Chambless and Hollon 
(1998) stated that some members of the American Psychological Association Task 
Force suggested efforts be made to take treatment utility into consideration. In order 
to take treatment utility into consideration, the American Psychological Association 
defined the term effectiveness as, “whether the treatment can be shown to work in 
actual clinical practice” (p. 14). 
Effectiveness can be a superior marker of utility due to the frequent concern 
that efficacy research, such as studies using RCTs, generalize poorly to practical 
clinical settings (Chambless & Hollon, 1998; Kazdin, 2008; Seligman, 1995); the 
lacking generalizability of efficacy research is often due to participant screening that 
eliminates comorbid concerns frequently encountered in the real world (Chambless 
& Hollon, 1998; Kazdin, 2008, 2011; Seligman, 1995). A spectrum of research 
exists between the most rigorous efficacy research using RCTs and the most 
practical and effectiveness research. Chambless and Hollon (1998) concluded that 
effectiveness studies utilizing quasi-experimental and non-experimental designs 
could serve to address questions regarding the clinical utility of some treatments. 
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In support of effectiveness studies, Seligman (1995) argued that 
effectiveness studies of how patients respond in “the actual conditions of treatment 
in the field” generate “useful and credible” validation of psychotherapy (p. 966). 
Seligman noted that a primary benefit to effectiveness studies is that they are 
conducted in the field with the population actually seeking out the researched 
treatment. Seligman acknowledged that non-random assignment of participants 
might lead to biases in the research; however, such non-random assignment is 
necessary when researching the practice of psychotherapy as it is done in the field 
(Seligman, 1995). Seligman stated that if clients were randomly assigned to a 
particular course of treatment, this would impact the non-random decisions of the 
clients and therapists that result in the selection of a particular treatment modality. 
Seligman concluded that, “appropriately assigning individuals to the right treatment, 
the right drug, and the right sequence of techniques, along with individuals' 
choosing a therapist and a treatment they believe in, may be crucial to getting better” 
(p. 974); this intent is similar to the American Psychological Association (1995) 
definition of effectiveness as a measure of clinical utility. For the purposes of this 
study, the effectiveness of treatment will be determined through research without 
random assignment conducted in real-world settings that answers the question, “Do 
the findings extend to practice settings?” (Kazdin, 2008, p. 151). 
PTSD Psychotherapy Research With Military Populations 
 The VA and DOD (2010) guidelines distinguished veterans from activity duty 
military personnel by noting that veterans are individuals who formerly served in the 
military but are now separated or discharged from the military. Speaking to the salient 
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differences between active military personnel and veterans, Tanielian et al. (2008) 
discussed how active duty military personnel (and their families) access and receive 
mental health services differently than military veterans. Specifically, veterans typically 
receive mental health care services as delivered through the VA system; in contrast, 
active duty military personnel, and their families, receive mental health treatment 
services through the Military Healthcare System (MHS) (Tanielian et al, 2008). Despite 
these noted differences, the majority of the analytic reviews of PTSD treatment done with 
military populations consist of research conducted with predominantly veterans and 
rarely with active duty military personnel (VA & DOD, 2010; IOM, 2012; Tanielian et 
al., 2008). 
While the VA and DOD (2010) guidelines represent collaboration between the 
VA and the DOD, these two organizations serve unique populations in distinctive 
situations. The current U.S. military population is entirely volunteer-based, and is more 
demographically diverse than military was in the 1990-1991 Gulf War or in the Vietnam 
War (IOM, 2012; Tanielian et al., 2008); specifically, the military presently consists of 
more women and more ethnic or racial minorities than ever before (IOM, 2012). As 
stated above, an estimated 2.6 million U.S. service members have served in Iraq or 
Afghanistan since 2001 (IOM, 2012). The prevalence of PTSD among these 2.6 million 
individuals ranged from 13% to 20%, equating to approximately 338,000 to 520,000 
service members with PTSD (IOM, 2012).  
The IOM (2012) noted a number of differences between the PTSD programs 
within the DOD compared to those within the VA. The DOD provides services to active 
duty personnel and their families through TRICARE. TRICARE is a major component of 
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the MHS that delivers direct care through military treatment facilities (IOM, 2012). In 
addition, the TRICARE section of the MHS provides active military personnel access to a 
variety of mental health professionals: psychiatrists, clinical psychologists, certified 
psychiatric nurse specialists, clinical social workers, certified marriage and family 
therapists, mental health counselors, and pastoral counselors. In addition, in certain 
situations TRICARE provides purchased care for active military service members 
through civilian network and non-network healthcare professionals (IOM, 2012); 
furthermore, deployed active military service members may also receive treatment in 
combat theater, or be airlifted to the nearest large military hospital (Tanielian et al., 
2008). 
In addition to the DOD services provided to active military, the IOM (2012) 
reported that 438,091 veterans were treated through the VA medical system in 2010; 
however, while the VA offers specialized treatment programs that focus on PTSD, the 
majority of PTSD and PTSD-related services for veterans are delivered through general 
health, medical care, and primary care. In addition, the VA offers services through Vet 
Centers that are staffed by mental health professionals, including: clinical psychologists, 
social workers, and mental health counselors (Tanielian et al, 2008). 
While all of the U.S. military medical services provide PTSD treatment programs, 
the IOM (2012) reported that no single source within the DOD or any other government 
organization maintains a complete list of these programs; furthermore, no organization is 
tracking the development of new or emerging programs, or consistently directing service 
members to whichever program would best meet their needs (IOM, 2012). Relatedly, 
Tanielian et al. (2008) stated that due to gaps within the organization the MHS and 
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TRICARE, it was not possible to “provide oversight to ensure high quality of care” 
(p. xxv). In contrast to the DOD services, Tanielian et al. noted that the VA offers a 
model of quality improvement in mental health care they recommend the DOD consider 
adopting.  
Veteran and active military populations face different challenges regarding PTSD 
treatment. Tanielian et al. (2008) reported that the primary barrier preventing active duty 
personnel from pursuing mental health treatment was their concern that treatment would 
constrain future job assignments and career advancement within the military; such 
concerns do not necessarily generalize to the veteran population. In contrast, the VA’s 
challenges in providing veterans access to PTSD treatment appear to be due to difficulty 
with securing appointments, especially in facilities that have been designed primarily to 
meet the demands of an older veteran population. 
Summary of PTSD psychotherapy research with military populations. Active 
military and veterans are demographically distinct populations that access services in 
different ways through separate systems (IOM, 2012; Tanielian et al., 2008). Active 
military may receive mental health services at the time of injury detection, including 
receiving services in combat theater while deployed (Tanielian et al., 2008); in contrast, 
veterans typically receive mental health care through outpatient services at VA Vet 
Centers across the United States (IOM, 2012). A primary focus of the DOD MHS is to 
prepare active service members for deployment, including potential combat scenarios; in 
contrast, the VA is a community-based organization servicing veterans that principally 
provides the following outpatient services prioritization hierarchy: service-connected 
disability, former prisoner of war status, receipt of a Purple Heart, disability not 
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connected to service, income, and specific criteria including service in a war (IOM, 
2012). Due to the salient differences between the active military and veteran populations, 
the primary focus of this study is on active military personnel and their family members 
as opposed to retired veterans. 
Overview of Military-Related PTSD Psychotherapy Research  
Efficacy and effectiveness. Several literature reviews for treating PTSD among 
military populations have been conducted. The VA and DOD (2010) guidelines 
recommended ET, CT, SIT, and EMDR for the treatment of PTSD; however, the 
literature reviewed to determine these recommendations did not include effectiveness 
studies. Similarly, the IOM (2012) also reviewed the same EBTs (ET, CT, SIT, and 
EMDR), and the IOM stated that their recommendations were based solely on RCTs; as a 
result, effectiveness studies were again not taken into consideration. Tanielian et al. 
(2008) also reviewed ET, CT, SIT, and EMDR in their discussion of EBT treatments for 
PTSD. In contrast to the reviews by the VA and DOD (2010) and the IOM (2012), 
Tanielian primarily cited meta-analytic articles rather than specific RCT studies, making 
their inclusionary and exclusionary criteria for PTSD treatment studies unclear. Tanielian 
et al. (2008) most frequently cited Foa, Keane, and Friedman (2000) as a source of 
guidelines for the treatment of PTSD. Foa et al. focused explicitly on efficacy studies, 
and did not include any effectiveness research in their meta-analysis. 
Research with veterans and active military personnel. The IOM (2012) 
divided their discussion of EBTs into various sections for the different psychotherapies. 
In their discussion of ET, the IOM made note of 24 different studies (see Table 1); 
however, only six of those studies included veterans and none included active military 
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personnel. The IOM reviewed seven RCTs for CT, none of which included veterans or 
active military personnel. For EMDR, the IOM reviewed four studies, again none of 
which included veterans or active military personnel. The IOM also reviewed two RCTs 
for SIT, neither of which included veterans or active military personnel. The IOM (2012) 
explicitly noted that the treatments they discussed were not necessarily researched 
specifically with military service members or veterans.  
Table 1 
PTSD Psychotherapy Research Populations From Studies Reviewed by IOM (2012) 
ET 
Efficacy 
Studies 
CT 
Efficacy 
Studies 
SIT 
Efficacy 
Studies 
EMDR 
Efficacy 
Studies 
ET 
Effectiveness 
Studies 
CT 
Effectiveness 
Studies 
SIT 
Effectiveness 
Studies 
EMDR 
Effectiveness 
Studies 
Non-
military 
18 7 2 4 - - - - 
Veterans 6 - - - - - - - 
Active 
Military 
- - - - - - - - 
Tanielian et al. (2008) relied on research compiled by Foa et al. (2000) to 
determine the quality of PTSD EBTs. Foa et al. reviewed a number of EBTs, including 
ET, CT, SIT, and EMDR. In discussing ET, Foa et al. reported on 12 RCTs, six of which 
involved Vietnam veterans, and none of which included active military service members. 
Foa et al. referenced two RCTs for CT but did not clarify if those studies were with 
veterans or active service members. Similarly, for SIT, Foa et al. referenced four studies, 
all of which were conducted with female sexual assault survivors. In discussing EMDR, 
Foa et al. noted seven RCTs in total; Foa et al. indicated that other research on EMDR 
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had been conducted with veterans, but did not specify the number of studies or if active 
military personnel were included. 
Table 2  
PTSD Psychotherapy Research Populations From Studies Reviewed by Foa et al. (2000) 
ET 
Efficacy 
Studies 
CT 
Efficacy 
Studies 
SIT 
Efficacy 
Studies 
EMDR 
Efficacy 
Studies 
ET 
Effectiveness 
Studies 
CT 
Effectiveness 
Studies 
SIT 
Effectiveness 
Studies 
EMDR 
Effectiveness 
Studies 
Non-
military 
6 - 4 7 - - - - 
Veterans 6 2 - - - - - - 
Active 
Military 
- - - - - - - - 
In another meta-analysis on treatments for PTSD, Van Etten and Taylor (1998) 
examined studies on ET, CT, SIT, and EMDR. Of the 61 studies incorporated in this 
review, 15 included veterans; however, none of the research involved active military 
service members. Relatedly, Albright and Thyer (2010) conducted a meta-analysis 
specifically on the utilization of EMDR to treat PTSD in combat veterans. Of the nine 
studies reviewed, none contained active military personnel as participants. Furthermore, 
seven of the nine studies reviewed were specifically conducted with Vietnam veterans; 
the other two studies discussed were unclear in which war(s) their veterans participated. 
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Table 3 
PTSD Psychotherapy Research Populations From Studies Reviewed by Van Etten and 
Taylor (1998) 
 ET, CT, SIT, and 
EMDR Efficacy 
ET, CT, SIT, and 
EMDR Effectiveness 
Non-military  46 - 
Veterans 15 - 
Active Military - - 
 
Table 4 
PTSD Psychotherapy Research Populations From Studies Reviewed by Albright and 
Thyer (2010) 
 EMDR Efficacy EMDR Effectiveness 
Non-military  2 - 
Veterans 7 - 
Active Military - - 
 
Summary. The IOM (2012) recommended that the VA and DOD gather further 
data regarding the effectiveness of all PTSD interventions, including ET, CT, SIT, and 
EMDR. While the IOM noted the benefits of RCTs, their conclusion specifically noted 
that pilot studies and other measures could be beneficial. The IOM (2012) and Tanielian 
et al. (2008) both suggested that early intervention and treatment are likely to yield 
long-term benefits to the individual service members as well as society at large. 
Furthermore, in order to address the current gaps in the literature, Tanielian et al. 
recommended additional and sustained research on the effectiveness of psychotherapy 
interventions on military personnel with PTSD. Following the suggestions of the IOM 
(2012) and Tanielian et al. (2008), this study will address a gap in the literature regarding 
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the effectiveness of EBT interventions employed to treat PTSD in active military 
personnel. 
Purpose of This Study 
The literature will be examined regarding both the efficacy and effectiveness 
of evidence-based PTSD psychotherapy treatment conducted with active military 
personnel and their families; a greater emphasis will be placed on effectiveness due 
to this study’s focus on external validity and generalizability. Effectiveness research 
will be considered as studies that employed research methods that neither randomly 
assigned participants nor excluded participants due to concern for comorbid 
complications. Using existing meta-analytics as a basis (VA & DOD, 2010; IOM, 
2012; Tanielian et al., 2008), this study will review and discuss the relevant 
literature available since the publication of the VA and DOD (2010) guidelines. 
After reviewing the current state of the literature on PTSD psychotherapy 
effectiveness studies with active military populations, the recommendations of the 
IOM (2012) and Tanielian et al. (2008) will be followed. The current pilot study will 
report on the effectiveness of implementing a PTSD EBT, specifically EMDR, in the 
treatment of PTSD in active military personnel and their families in a military 
community setting. A partial model for effectiveness research will be provided, 
thereby addressing an established gap in the literature. Furthermore, this study will 
attend to some of the noted limitations of effectiveness research by including a 
larger population than usual as well as a larger number of more commonly utilized 
outcome treatment measures.  
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Chapter II: Current Literature on U.S. Military Related PTSD Treatment Research 
This literature review examines the current efficacy literature conducted on 
PTSD treatment with U.S. active military and veteran populations published since 
2010 regarding the EBTs recommended by the VA and DOD (2010) guidelines: 
Cognitive Therapy (CT), Exposure Therapy (ET), Stress Inoculation Training (SIT), 
and Eye Movement Desensitization and Reprocessing (EMDR). Efficacy research 
will be considered to be RCT studies designed to assess if treatment works in a 
controlled setting. Given that the VA and DOD (2010) guidelines and existing 
meta-analyses (IOM, 2012; Tanielian et al., 2008) did not include effectiveness 
studies in their literature reviews or discussions, the topic will be explored and 
expand upon. Effectiveness research on the VA and DOD recommended EBTs of 
PTSD, conducted with active military and veterans, will be the focus.  
Due to the gap in the literature regarding effectiveness research, especially 
with active military populations, the current literature review will examine 
effectiveness studies with military populations published since the release of the VA 
and DOD (2004) guidelines. Effectiveness research will be considered to be studies 
that employed research methods that neither randomly assigned participants nor 
excluded participants due to concern for comorbid complications. In addition, in 
order to best incorporate literature on this topic, multiple-case studies conducted 
utilizing the relevant therapies with the target populations will be included; however, 
as a primary focus of effectiveness research is external validity and generalizability, 
individual case studies will not be reviewed. A summary of military-related 
effectiveness research is provided and the noteworthy exclusion of effectiveness 
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studies from the analysis of the VA and DOD (2010) guidelines, as well as the IOM 
(2012) and Tanielian et al. (2008) meta-analyses, is highlighted; in addition, tables 
synopsizing the reviewed literature are provided at the end of both the efficacy and 
effectiveness sections. 
Although the VA and DOD (2010) guidelines reported concerns regarding the 
generalizability of RCTs, the studies included were limited to efficacy research. The 
inclusionary criteria for the studies included in the VA and DOD guidelines were:  
Published in United States, United Kingdom, Europe, Australia, Japan, New 
Zealand; Full articles only published in English; Study populations: age 
limited to adults 18 years of age or older; all races, ethnicities, and cultural 
groups; Relevant outcomes able to be abstracted from the data presented in 
the articles; Sample sizes appropriate for the study question addressed in the 
paper. RCTs were included if they were initiated with 30 or more 
participants (p. 200). 
 
Inclusionary and exclusionary criteria. In addition to the above criteria 
regarding the definition of efficacy research and effectiveness research, articles were 
included if the following standards were met: (1) participants were diagnosed with a 
traumatic stress injury; (2) two or more participants were included; (3) treatment 
outcome was presented in terms of self-report or observer-rated measures; (4) 
participants were from a United States of America military population (i.e., active 
military or veteran); (5) studies were researching one of the VA and DOD (2010) 
recommended EBTs for PTSD: ET, CT, SIT, and EMDR. 
PTSD Treatment Efficacy Studies With U.S. Military Populations Since 2010 
Cognitive therapies. Macdonald, Monson, Doron-Lamarca, Resick, and Palfai 
(2011) conducted an RCT utilizing cognitive processing therapy (CPT) with 60 veterans 
diagnosed with PTSD due to military trauma. The study did not include any active 
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military participants. The veterans involved in the study primarily served in Vietnam, 
although Macdonald et al. noted 17 of their participants served in “other” conflicts 
(p. 270). Exclusionary criteria for the study by Macdonald et al. included: current 
substance abuse or dependence, current suicidal ideation (SI) or homicidal ideation (HI), 
current uncontrolled psychotic or bipolar disorder, significant cognitive impairment, and 
unstable psychopharmacological regimen (researchers required two months of stability 
on medication). There was a 16.6% overall dropout rate from therapy; however the 
average number of sessions completed was not reported. Using the PTSD Checklist for 
Military (PCL-M) and the Clinician Administered PTSD Scale (CAPS) as outcome 
measures, Macdonald et al. found a significant improvement in participants who received 
CPT compared to their waitlist condition.  
Similarly, Surís, Link-Malcolm, Chard, Ahn, and North (2013) conducted an RCT 
using CPT as the treatment for PTSD resulting from military-related sexual trauma 
among 86 (73 female, 12 male) veterans of unspecified eras; no active military 
participants were involved. The exclusionary criteria noted by Surís et al. included: 
current psychotic symptoms, current substance dependence (within the last three months), 
current unstable bipolar disorder, current SI or HI, severe cognitive impairment, and 
current involvement in a violent relationship. Surís et al. assessed symptomology with the 
PTSD Checklist (PCL), the CAPS, and the Quick Inventory of Depressive 
Symptomatology (QIDS). Participants completed an average of ten sessions. While 28% 
of participants dropped out of the study (35% from the CPT condition and 18% from the 
control condition), Surís et al. found a significant difference in the CPT group, supporting 
the efficacy of the treatment.  
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Exposure therapies. Tuerk, Yoder, Ruggiero, Gros, and Acierno (2010) 
conducted a pilot study wherein 12 Operation Enduring Freedom (OEF) and Operation 
Iraqi Freedom (OIF) veterans previously diagnosed with combat-related PTSD were 
treated using prolonged exposure (PE) therapy through telehealth technology. No formal 
inclusionary or exclusionary criteria were reported, and no active military personnel were 
involved in the study. Tuerk et al. administered the PCL-M and the Beck Depression 
Inventory-II (BDI-II) both pre-treatment and post-treatment as outcome measurements. 
Of the 12 participants receiving telehealth treatment, three dropped out before completing 
five sessions; the remaining nine participants completed an average of 10 sessions that 
were 90-minutes long. As a result, the total average number of sessions completed was 
seven, and the dropout rate for the entire study was 25%. For treatment completers, Tuerk 
et al. reported a clinically and statistically significant decrease in PTSD symptomology 
according to the PCL-M self-report measure. In addition, there was also a clinical and 
statistical decrease in BDI-II scores. In comparing telehealth PE to an in-person PE 
sample of 35 participants, Tuerk et al. concluded that there was a slightly higher dropout 
rate for telehealth participants. 
More recently, Price, Gros, Strachan, Ruggiero, and Acierno (2013) conducted a 
RCT researching the treatment of 111 OEF and OIF veterans with ET. None of the 
participants were active military personnel, and no formal inclusionary or exclusionary 
criteria were reported. Of the 111 veteran participants, 101 were male, 56 were 
Caucasian, and 49 were African American. In addition, 72 of the participants were 
diagnosed with PTSD, while 39 subjects were sub-threshold for PTSD according to the 
CAPS. Outcome measures included the BDI-II, the CAPS, the PCL-M, the Combat 
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Experiences Scale (CES), and the Deployment Risk and Resiliency Inventory (DRRI). 
The participants received eight weeks of ET, although the average number of sessions 
completed and the treatment dropout rate were note reported. Price et al. noted that 
BDI-II and PCL-M scores had decreased throughout treatment; however, increased 
combat exposure was related to a lower rate of change in PTSD symptoms, but not in 
depression symptoms. 
Summary of the Efficacy Research With U.S. Military Populations Since 2010 
As seen in Table 5, since 2010 only four efficacy studies were found that 
researched the application of the four top tier psychotherapy treatments, with military 
populations, as recommended by VA and DOD (2010) guidelines. Of these four studies, 
all focused on veteran participants. As a result, none were conducted with active military 
populations. Additionally, two of these studies researched ET (Price et al., 2013; Tuerk et 
al., 2010), and two researched CT (Macdonald et al., 2011; Surís et al., 2013); no studies 
researched either SIT or EMDR. 
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Table 5 
EBT Efficacy Research With U.S. Military Populations Since 2010 
Study and Treatment Modality Trauma Type and 
Diagnoses 
Population Number of 
Subjects 
Psychometric Measures Average Number of 
Sessions Completed 
Completion 
Rate 
Improvement 
Rate 
Tuerk et al. (2010)  
Prolonged Exposure Therapy 
Combat-related PTSD Veterans (OIF and OEF) n = 65 PCL-M, BDI-II 7 75% - 
Macdonald et al. (2011)  
Cognitive Processing Therapy 
PTSD due to military 
trauma 
Veterans (Vietnam and 
Other) 
n = 60 CAPS, PCL-M - 83.4% - 
Surís et al. (2013)  
Cognitive Processing Therapy 
PTSD resulting from 
military-related sexual 
trauma 
Veterans (Unspecified) n = 86 CAPS, PCL, QIDS 10.1 72% - 
Price et al. (2013) 
Exposure Therapy 
PTSD and PTSD 
symptoms. 
Veterans (OIF and OEF) n = 111 BDI-II, CAPS, PCL-M, 
CES, DRRI 
- - - 
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PTSD Treatment Effectiveness Studies With U.S. Military Populations Since 2004 
Cognitive therapies. Zappert and Westrup (2008) studied the effectiveness of 
CPT with 18 female veterans, with an average age of 44.6 years old, in a residential 
treatment facility for trauma recovery. No formal inclusionary or exclusionary criteria 
were reported, and none of the participants were active military service members. No 
participants dropped out, and participants completed an average of 12 sessions. 
Modifying the standard CPT protocol, Zappert and Westrup conducted treatment in a 
group setting to accommodate the practical limitations of the treatment site. Using the 
PCL to assess outcomes, Zappert and Westrup found that 15 of the 18 participants 
reported a clinically significant decrease in PTSD symptomology. 
In an effort to explore different responses to treatment, Chard, Schumm, Owens, 
and Cottingham (2010) compared a sample of outpatient veterans from OEF and OIF to a 
sample of veterans from Vietnam; no active military participants were included. 
Comparisons were made before and after treatment of combat-related PTSD using CPT. 
No formal inclusionary or exclusionary criteria were noted. Chard et al. employed the 
BDI-II, the PCL, and CAPS as pre- and post-measures. The OEF and OIF study 
participants consisted of 101 veterans, with an average age of 30.9, who received 
treatment between 2005 and 2008 at a Veterans Administration Medical Center PTSD 
Clinic or an OEF/OIF clinic. The average number of sessions completed by OEF/OIF 
veterans was 10.67, and for Vietnam veterans it was 13.24. Vietnam veterans had a 
dropout rate of 26%, while OEF/OIF veterans had a dropout rate of 35%. All of the 101 
veteran participants met full criteria for PTSD pre-treatment. While Chard et al. primarily 
focused on the similarities and differences between Vietnam veterans and OEF/OIF 
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veterans, the study reported that 69% of the OET and OIF veterans no longer met criteria 
for PTSD after completion of treatment; in contrast, 40% of the Vietnam veterans no 
longer met PTSD criteria after receiving CPT. 
In another effectiveness study on veterans, Alvarez et al. (2011) employed a 
retrospective method when researching the effectiveness of group CPT compared to 
trauma-focused group treatment as usual (TAU), in the context of a Veterans Health 
Administration (VHA) PTSD residential rehabilitation program. Participants included 
197 male veterans, with an average age of 52 years, who exhibited symptoms of PTSD. 
No participants were active military personnel. Furthermore, the average number of 
sessions completed was not reported; nor was the dropout rate for participants. Clinical 
outcomes were assessed using a variety of measures, including: the PCL, the Beck 
Depression Inventory (BDI), the World Health Organization Quality of Life-BREF 
(WHOQOL-BREF), the Brief COPE, and the Symptom Checklist (SCL-6). Alvarez et al. 
found that the 14-session cognitive processing therapy group evidenced “demonstrated 
significantly more improvement” at discharge than the 15-session TAU group (p. 596). 
Dickstein, Walter, Schumm, and Chard (2013) conducted effectiveness research 
on CPT with two groups of veterans: one was diagnosed PTSD, and one was found to 
have sub-threshold PTSD. Dickstein et al. reported that their study was, to the best of 
their knowledge, the first effectiveness study of a trauma-focused EBT with a sub-
threshold PTSD population. Their 534 participants were veterans of unspecified wars 
who had completed at least one session of individual, outpatient CPT at a VA outpatient 
specialty clinic. Participants were 48 years old on average, and 96% were male; no 
participants were active military service members. The mean number of CPT sessions 
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completed by participants was 8.44; however, the dropout rate of participants was not 
reported. Of the 534 participants, 483 (90.4%) met full criteria for PTSD, while the 
remaining 51 (9.6%) met criteria for sub-threshold PTSD. Dickstein et al. employed the 
CAPS, PCL, and BDI-II as outcome measures for tracking treatment progress; the results 
found a significant decrease in PTSD symptoms in both the PTSD participant group and 
the sub-threshold PTSD participant group. 
Furthermore, Castillo, Lacefield, Baca, Blankenship, and Qualls (2014) studied 
group cognitive therapy employed in the treatment of female veterans with PTSD. The 
participants were 271 female veterans of an unspecified war with an average age of 45. 
The participants did not include any active military personnel. The data for this 
effectiveness study was collected from 51 PTSD treatment groups held at a southwest 
VA clinic between 1995 and 2013. The outcome measures utilized with the group 
cognitive treatment included the CAPS and the PCL. Most of the participants (82%) 
experienced more than one trauma, and sexual trauma was the most frequently reported 
trauma (53%). In addition, 63% of the participants were diagnosed with a comorbid 
psychiatric disorder, and no exclusionary criteria for the study were noted.  Castillo et al. 
stated that 36.6% of participants dropped out of treatment, although the average number 
of treatment sessions completed was not noted. Castillo et al. reported that 20% of 
participants no longer met criteria for PTSD after treatment, and that one third of 
participants experienced a decrease of at least 10 points on the post-treatment PCL 
outcome measure. 
Kaysen et al. (2014) conducted an effectiveness study comparing the CPT 
treatment of two groups of veterans: those with comorbid PTSD and alcohol use 
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disorders, and those only diagnosed with PTSD. The 536 participants were 90% male, 
and reported an average age of 44. The largest group of veterans was from OEF and OIF 
(39.7%), but there were also veterans from Vietnam (32.7%), post-Vietnam (11.8%), and 
the Persian Gulf (14.7%); in addition, three veterans (1.1%) were pre-Vietnam. None of 
the participants were active military. Half of the total sample, 264 (49.3%) participants, 
endorsed a current or past alcohol use disorder diagnosis, making the group sizes nearly 
even. Participants completed an average of nine sessions, although the dropout rate for 
participants was not reported. Kaysen et al. utilized the CAPS, PCL, and BDI-II as 
outcome measures for CPT treatment. Results indicated that veterans with and without 
alcohol use disorders attended treatment equally, and that treatment was effective with 
both groups. No negative interaction was found between alcohol use disorders and 
treatment outcome. 
Exposure therapies. Rauch et al. (2009) conducted research on PET treatment 
with 10 veterans diagnosed with PTSD in a Veterans Health PTSD clinic. Eight of the 
participants were male, two were female, and the average age was 39 years old. No 
formal inclusionary or exclusionary criteria were utilized, and no participants in the study 
were active military service members. The average number of sessions completed was 
12.7, and no participants dropped out of the study. Treatment outcomes were measured 
through the following pre- and post-outcome assessments: Posttraumatic Diagnostic 
Scale (PDS), BDI-II, Post-traumatic Cognitions Inventory (PCI), Dissociative 
Experiences Scale (DES), Spielberger Trait Anger Inventory (STI), CAPS, and Mini 
International Neuropsychiatric Interview (MINI). Rauch et al. found significant reduction 
in symptoms across all of the outcome measures utilized. In addition, the effect sizes 
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were consistent with results seen in RCTs conducted with both non-veteran and veteran 
populations.  
McLay, McBrien, Wiederhold, and Wiederhold (2010) discussed a parallel case 
series of ten active duty service members receiving ET treatment, with and without 
virtual reality (VR), for combat PTSD. This case series documented the first known 
usage of VR to treat PTSD in a combat theater, and no participants dropped out. Four of 
the participants, with an average age of 24.5 years old, received typical ET treatment, and 
completed a mean of nine sessions; six of the participants, with an average age of 26.5 
years old, received VR ET treatment, and completed a mean of 6.5 sessions. Pre- and 
post-treatment outcomes for both groups were measured utilizing the PCL-M. McLay et 
al. found that both groups demonstrated significant improvement after treatment. Five of 
the six ET with VR group participants no longer met criteria for PTSD; in addition, all 
four of the ET group participants no longer met criteria for PTSD. As a result, it was 
concluded that both ET and ET with VR were safe and effective treatments for 
combat-related PTSD in a combat theater. 
Cigrang et al. (2011) reported findings from a pilot study examining the 
effectiveness and practicality of ET treatment in a real-world setting. The treatment 
participants were 15 active duty OIF and OEF veterans, with an average age of 39, all 
previously diagnosed with PTSD. Cigrang et al. noted exclusion criteria that, “mirrored 
patient characteristics that were likely to result in a referral to specialty mental health in 
routine clinical care” (p. 107). These criteria included: serious suicide risk, current 
psychotic disorder, current alcohol dependence, significant dissociative disorder, and 
severe brain injury. Cigrang et al. utilized the PCL-M as a pre- and post-treatment 
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outcome measurement, as well as the Behavioral Health Measure (BHM) and the PTSD 
Symptom Scale, Interview Version (PSS-I). Five participants dropped out after one or 
two sessions, while the remaining 10 participants completed an average of four and 
one-half 30-minute appointments; the average number of sessions attended was 4.5. 
Cigrang et al. stated that PTSD symptom severity and depression both significantly 
improved after treatment, and 50% of the participants were found to no longer met 
criteria for PTSD during the one-month post-treatment follow up. Cigrang et al. 
concluded that PE was effective in this real-world setting, and that brief therapy resulted 
in a substantial decrease in deployment-related PTSD. 
Similarly, Reger et al. (2011) noted the lack of literature regarding the 
effectiveness of ET with active military populations and conducted a study on the 
effectiveness of Virtual Reality (VR) Exposure Therapy. Reger et al. used the PCL-M to 
study the treatment outcomes of VR ET with 24 active-duty soldiers over an average of 
7.4 sessions; the dropout rate of participants was not reported. No formal inclusionary or 
exclusionary criteria were used. Reger et al. found that 45% of participants no longer 
screened positive for probable PTSD, and 62% of participants had “reliably improved” 
on the PCL-M by decreasing their score by at least 11 points (p. 95).  
Strachan, Gros, Ruggiero, Lejuez, and Acierno (2012) also researched the 
effectiveness of exposure-based treatment for symptoms of both PTSD and depression in 
combat-exposed OEF and OIF veterans. The study did not include any active military 
participants. Individuals excluded from the study included those who were: suicidal, 
actively psychotic, or met criteria for substance and/or alcohol dependence; however, 
Strachan et al. noted that, “to enhance generalizability of study findings”, participants 
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who were taking prescription psychotropic medications were allowed in the study, as 
were individuals receiving case management services for PTSD, mental health treatment 
for other psychiatric disorders, as well as those who met criteria for alcohol or substance 
abuse (pp. 562-563). Measuring outcomes with the CAPS, BDI-II, Beck Anxiety 
Inventory (BAI), structured clinical interview for DSM-III-R (SCID), and PCL-M, 
Strachan et al. treated 40 combat veterans for eight sessions; results indicated significant 
reduction in PTSD, depression, and anxiety as evidenced by the PCL-M, BDI-II, and 
BAI. No participant dropout rate was reported. Strachan et al. concluded these results 
supported the effectiveness of their therapeutic approach. 
In another effectiveness study, Yoder et al. (2012) researched PET treatment 
outcomes with veterans from different wars diagnosed with PTSD. Participants included 
112 veterans from the Vietnam War, the first Persian Gulf War, and the wars in 
Afghanistan and Iraq; however, no active military personnel were included. There were 
no exclusionary criteria reported, and all veterans had been previously diagnosed with 
PTSD, and the average age of the sample was 41. Veterans from the 
OEF/OIF/Afghanistan wars completed an average of 8.2 sessions with a dropout rate of 
26%. The mean number of sessions completed by veterans of the first Persian Gulf War 
was 9.7, and the dropout rate was 12%. Vietnam veterans completed 10.2 sessions and 
had a dropout rate of 3%. For tracking treatment outcomes, Yoder et al. employed the 
PCL-M and the BDI-II. Researchers found a large effect size for PET treatment of the 
Vietnam veterans, first Persian Gulf War veterans, and the OEF/OIF/Afghanistan 
veterans; however, there were notable differences in response to treatment across the 
different theaters of war. Yoder et al. reported that “treatment effect size for Gulf War era 
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veterans was lower than the treatment effect sizes for Vietnam and OEF/OIF/OND 
veterans, and Gulf War era veterans’ symptoms declined at significantly slower rates than 
those of the other two cohorts” (pp. 7-8). In addition, the study found that veterans from 
more recent conflicts (OIF/OEF/Afghanistan) completed treatment at a lower rate than 
veterans from older conflicts (Vietnam and the first Persian Gulf War). 
Goodson, Lefkowitz, Helstrom, and Gawrysiak (2013) conducted a study 
regarding the effectiveness of PE treatment of PTSD. Goodson et al. treated 115 veterans 
from unspecified eras gathered from VA-related clinics, including those from the PTSD 
clinical team (n = 58), the general mental health clinic (n = 22), community- based 
outpatient clinics (n = 12), the addictions recovery unit (n = 11), the primary care mental 
health facility (n = 7), the opioid treatment program (n = 3), as well as the polytrauma 
unit (n = 2). No active military service members participated in the study. Participants 
were assessed using the PCL-M, Patient Health Questionnaire-9 (PHQ-9), and the 
Behavioral Health Questionnaire-20 (BHQ-20). Throughout the study, 25 different 
providers treated the 115 participants for the PTSD utilizing PE, and 84 completed 
treatment (73%). The mean number of sessions attended was 12. Of the participants, 86% 
were male, and of the total participants, 87 participants reported combat related trauma: 
“Vietnam = 42%; OEF/OIF = 28%; and Persian Gulf war = 5%,” while the rest of the 
participants reported non-combat related trauma (p. 422). Furthermore, 86% of 
participants were diagnosed with a comorbid mental health disorder: including 78 
participants with a depressive disorder, 32 with a substance use disorder, 13 with a 
non-PTSD anxiety disorder, and 13 with a traumatic brain injury. Goodson et al. stated 
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that participants completed 12 sessions on average, and outcome measurements indicated 
a 41% reduction of symptoms. 
Stress Inoculation Training. McKibben, Britt, Hoge, and Castro (2009) 
examined the effectiveness of stress management training by comparing several outcome 
variables, including PTSD, among veterans who did and did not receive the training. No 
formal inclusionary or exclusionary criteria were reported, and no participants were 
active military personnel. The participants were 97% were male, and 72% reported 
receiving stress management training in the last year. McKibben et al. were determining 
the results of previously administered stress management training, so there was no 
dropout rate due to the absence of treatment sessions. PTSD symptoms of participants 
were assessed using the PCL; results indicated that stress management training was 
effective, due to the fact that veterans who received stress management training reported 
significantly fewer PTSD symptoms compared to those who did not receive stress 
management training. 
Eye Movement Desensitization and Reprocessing. Russell (2006) reported a 
multiple case study of EMDR treatment of combat-related stress disorders. Four combat 
veterans from the Iraq War requested “immediate relief of their posttraumatic symptoms 
prior to returning to the United States” (p. 1); all participants were active military. The 
four participants were assessed pre- and post-treatment using the SCID the Impact of 
Event Scale (IES), and the Subjective Units of Distress Scale (SUDS), and two were 
diagnosed with Acute Stress Disorder (ASD) while two others were diagnosed with 
PTSD. None of the participants dropped out. Due to the time constraints of the treatment 
situation, EMDR was provided in an abbreviated form, and all clients received one 
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session of EMDR treatment. Specifically, the focus of treatment was on the stabilization 
of symptoms for medical evacuation purposes. As a result, the installation and body scan 
phases of EMDR were omitted. Russell reported a significant improvement in all four 
clients after one session as measured by the IES and the SUDs. 
Russell, Silver, Rogers, and Darnell (2007) conducted an effectiveness study 
regarding the EMDR treatment of active military personnel with PTSD. Researchers 
reviewed the treatment data from 72 active military personnel diagnosed with PTSD; of 
these cases, 48 were combat-related. Of the 72 participants, the average age was 32.5 
years old, the average number of EMDR sessions was 4.2, and no participants dropped 
out. The average time since the participant’s trauma was 9.4 months, and no exclusionary 
criteria were indicated; researchers placed an emphasis on combat-related PTSD, 
however this was not an inclusionary criteria. Russell et al. found a significant 
improvement in PTSD symptomology as indicated by the post-outcome measurements 
from the SUDs, Validity of Cognition Scale (VOC), Impact of Events Scale - Revised 
(IES-R), and BDI. Eight of the 72 participants had been wounded, and while no 
differences were found in treatment outcomes between wounded and non-wounded cases, 
individuals who were wounded averaged a higher number of EMDR sessions (8.5 
sessions, compared to 3.82 for non-wounded participants). 
Silver, Rogers, and Russell (2008) examined two case studies involving EMDR 
treatment of veterans previously diagnosed with PTSD; neither case study involved 
active military personnel. The first case study was a 22-year-old veteran of two tours in 
the Iraq war who was diagnosed with combat-related PTSD. Silver et al. described the 
participant’s distress and PTSD symptomology using the SUDs outcome measure; after 
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four sessions of EMDR, the participant was able to resolve his PTSD. The second case 
was a 73-year-old Vietnam veteran diagnosed with “PTSD, anxiety, depression, and 
chronic and combat-related medically unexplained symptoms of frequent myoclonic 
movements that began in 1968” (p. 954). The participant received three sessions of 
EMDR treatment, and his progress was assessed utilizing the SUDs, the IES, the BDI, 
and the Beck Hopelessness Scale (BHS). Silver et al. concluded that EMDR was 
effective in treating both veterans, as indicated by improvements in treatment outcome 
scores. 
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Table 6 
EBT Effectiveness Research With U.S. Military Populations Since 2004 
Study and Treatment 
Modality 
Trauma Type and 
Diagnoses 
Population Number of 
Subjects 
Psychometric Measures Average Number of 
Sessions Completed 
Completion Rate Improvement Rate 
Russell (2006) 
Eye Movement Desensitization 
and Reprocessing 
PTSD and ASD Active Military n = 4 SCID, SUDs, IES 1 100% 100% 
Russell et al. (2007) 
Eye Movement Desensitization 
and Reprocessing 
PTSD Active Military n = 72 SUDs, VOC, IES-R, BDI 4.2 100% - 
Silver et al. (2008) 
Eye Movement Desensitization 
and Reprocessing 
PTSD Veterans (Iraq, 
Vietnam) 
n = 2 SUDs, BDI, IES, BHS 3.5 100% 100% 
Zappert and Westrup (2008) 
Cognitive Processing Therapy 
PTSD Female Veterans 
(Unspecified) 
n = 18 PCL 12 100% 83.3% 
Rauch et al. (2009) 
Prolonged Exposure Therapy 
PTSD Veterans (Vietnam, 
OIF/OEF) 
n = 10 PDS, BDI-II, PCI, DES, STI, 
CAPS, MINI 
12.7 100% 90% 
McKibben et al. (2009) 
Stress Inoculation Therapy 
PTSD Veterans (OIF) n = 1760 PCL N/A N/A - 
McLay et al. (2010) 
Exposure Therapy and Virtual 
Reality Exposure Therapy 
PTSD Active Military n = 6 PCL-M ET = 9 
VR ET = 6.5 
100% 90% 
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Chard et al. (2010) Cognitive 
Processing Therapy 
Combat-related 
PTSD 
Veterans (OIF and 
OEF compared to 
Vietnam) 
n = 101 CAPS, PCL, BDI-II OEF/OIF = 10.67 
Vietnam = 13.24 
OEF/OIF = 65% 
Vietnam = 74% 
OEF/OIF = 69% 
Vietnam = 40% 
Alvarez et al. (2011) Group 
Cognitive Processing Therapy 
PTSD symptoms Veterans (Vietnam, 
Iraq/Afghanistan, and 
Other) 
n = 197 PCL, BDI, WHOQOL-BREF, 
Brief COPE, SCL-6 
- - 41.3% 
Cigrang et al. (2011) Exposure 
Therapy 
PTSD Active Military (OIF 
and OEF Veterans)  
n = 15 PCL-M, PSS-I, PHQ-9, BHM, 
Beck Scale for Suicidal 
Ideation (SSI), DRRI 
4.5 66% 50% 
Reger et al. (2011) Virtual 
Reality Exposure Therapy 
PTSD, anxiety 
disorder NOS 
Active Military (OIF 
and OEF Veterans) 
n = 24 PCL-M 7.4 - 65% 
Strachan et al. (2012) 
Exposure Therapy 
PTSD, PTSD 
symptoms, and 
Depression 
Veterans (OIF and 
OEF) 
n = 40 CAPS, BAI, BDI-II, PCL-M, 
Structured Clinical Interview 
for DSM-IV (SCID-IV) 
8 77.5% - 
Yoder et al. (2012) 
Prolong Exposure Therapy 
PTSD Veterans (Vietnam, 
Gulf War, 
Afghanistan, OEF, 
OIF) 
n = 112 PCL-M, BDI-II OEF/OIF/ 
Afghanistan = 8.2 
First Persian Gulf War = 
9.7 
Vietnam = 10.2 
OEF/OIF/ 
Afghanistan = 
74% 
First Persian Gulf 
War = 88% 
Vietnam = 97% 
- 
Goodson et al. (2013)  
Prolonged Exposure Therapy 
PTSD Veterans (Unspecified) n = 115 PCL-M, PHQ-9, BHQ-20 12 73% 41% 
Dickstein et al. (2013) PTSD and sub- Veterans (Unspecified) n = 534 CAPS, PCL, BDI-II 8.44 - - 
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Cognitive Processing Therapy threshold PTSD 
Castillo et al. (2014) 
Group Cognitive Therapy 
PTSD Veterans (Unspecified) n = 271 CAPS, PCL - 63.4% 55% 
Kaysen et al. (2014) 
Cognitive Processing Therapy 
PTSD and alcohol 
use disorders 
Veterans (Pre-
Vietnam, Vietnam, 
Gulf War, OEF, OIF) 
n = 536 CAPS, PCL, BDI-II 9 - - 
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Summary of the Effectiveness Research With U.S. Military Populations Since 2004 
Since 2004, only 17 effectiveness studies were found that researched the 
application of the four top tier psychotherapy treatments, with military populations, as 
recommended by VA and DOD (2010) guidelines. Although, of these 17 studies, only 
five were conducted with active military service members: Russell (2006), Russell et al. 
(2007), McLay et al. (2010), Cigrang et al. (2011), and Reger et al. (2011). Both Russell 
(2006) and Russell et al. (2007) researched EMDR treatment of activity duty military 
with PTSD. McLay (2010) researched ET and VR ET with PTSD-diagnosed active 
military, while both Cigrang et al. (2011) and Reger et al. (2011) researched ET treatment 
of active duty service members with PTSD. Furthermore, Russell (2006), Russell et al. 
(2007), and Silver et al. (2008) were the only three studies found by this literature review 
that researched the effectiveness of EMDR with military personnel, and only Russell 
(2006) and Russell et al. (2007) involved active military participants. 
Outcome Measures and Sample Sizes 
Outcome measures and sample sizes are presented in Table 6. There was 
consistency seen in outcome measures for the effectiveness studies reviewed. Across the 
17 effectiveness studies found by this review, the most common outcome measurements 
employed were: some form of the PCL (PCL or PCL-M), some form of the BDI (BDI or 
BDI-II), and the CAPS. In regards to the sample sizes seen in effectiveness studies, eight 
of the studies reviewed included sample sizes over 100: McKibben et al. (2009) reported 
n = 1760; Chard et al. (2010) stated n = 101; Alvarez et al. (2011) noted n = 197; Yoder 
et al. (2012) reported n = 112; Goodson et al. (2013) reported n = 115; Dickstein et al. 
(2013) stated n = 534; and; Castillo et al. (2014) noted n = 271; and Kaysen et al. (2014) 
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noted n = 536; in contrast, several other studies reported sample sizes under 50: Russell 
(2006) reported n = 4; Silver et al. (2008) noted n = 2; Rauch et al. (2009) reported 
n = 18; Zappert and Westrup (2008) shared n = 10; McLay et al. (2010) stated n = 6; 
Strachan et al. (2012) shared n = 40, Reger et al. (2011) noted n = 24, and Cigrang et al. 
(2011) reported n = 15.  
Requests for Effectiveness Research 
The IOM (2012) recommended that the VA and DOD institute programs to gather 
data and research the effectiveness of all PTSD treatment interventions, including their 
recommended EBTs of ET, CT, SIT, and EMDR (p. 13). The IOM made note of the 
benefits of RCT research and emphasized how a lack of research regarding the clinical 
application of researched PTSD interventions represents a barrier to care for military 
personnel (p. 341). Both the IOM (2012) and Tanielian et al. (2008) recommended 
further research regarding effectiveness of PTSD EBTs utilized with military personnel; 
however, neither Tanielian et al. nor the IOM (2012) reviewed available effectiveness 
research when making their conclusions. Similarly, while the VA and DOD (2010) 
guidelines noted concerns regarding the external validity and generalizability of RCTs, 
the VA and DOD failed to include any effectiveness studies in their literature review. 
Table 7 
Requests for Effectiveness Research Contrasted With Reviews of Available Effectiveness 
Research 
 Requested Effectiveness Research  Reviewed Available Effectiveness Research 
VA and DOD (2010) Yes No 
IOM (2012) Yes No 
Tanielian et al. (2008) Yes No 
Bradley et al. (2005) Yes No 
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Military Population Access to EBTs for PTSD 
While VA and DOD (2012) guidelines endorse CT, ET, SIT, and EMDR as 
psychotherapy treatments for PTSD, the Congressional Budget Office (CBO, 2012) noted 
that the VA only guarantees access to CPT and PE. Relatedly, Russell and Silver (2006) 
found that only 10% of 137 surveyed DOD clinicians were trained to use any of the four 
VA and DOD recommended EBTS for PTSD. Regarding EMDR in particular, despite the 
recognition of EMDR as an EBT for PTSD, and the requests for further efficacy and 
effectiveness research, there is an absence of any funded RCTs on EMDR since 1998 
(Russell, 2008b). While there is established resistance towards EMDR, the failure to 
appropriately research and utilize any established EBT for PTSD restricts scientific 
discovery as well as military personnel access to PTSD treatment (Russell, 2008b). 
Controversies Regarding EMDR Research 
Although they recommend EMDR as an EBT for PTSD, the VA and DOD (2010) 
guidelines also cited Jensen (1994) as an efficacy study that indicated that EMDR might 
be “less than optimal” for the treatment of PTSD (p. 130). Jensen conducted an efficacy 
study of the treatment of PTSD using EMDR with 25 veterans. Vietnam combat veterans 
were randomly assigned to either a control condition or to EMDR treatment; however, 
there were several methodological concerns in the study. For example, the therapists 
delivering the EMDR therapy were psychology interns with no clinical experience with 
EMDR. In addition, the 13 clients assigned to the EMDR treatment condition received 
only two treatment sessions. Furthermore, due to the wording of the consent form, control 
subjects knew after random assignment that they were not in the experimental group, 
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potentially biasing their outcome measures. Also, due to the relatively small sample size 
of the Jensen study, there may be insufficient statistical power to draw valid conclusions 
from the results. Finally, the independent fidelity reviewer noted insufficient fidelity with 
EMDR protocols, and specifically stated that, “the therapists did not appear to stay with, 
or continue in the active treatment phase with the videotaped subjects long enough to 
achieve resolution of symptoms” (Jensen, 1994, p. 321). Despite these limitations, Jensen 
found that post-test assessment of PTSD symptoms in the EMDR treatment group, as 
demonstrated by the Structured Interview for PTSD, failed to differ significantly from 
those of the control group. While it was noted that EMDR appeared effective in reducing 
“in-session anxiety upon exposure to traumatic cues,” Jensen concluded that the data was 
insufficient “to support the effectiveness of EMD/R with Vietnam combat veterans” 
(p. 321).  
In addition, skepticism and controversy exists regarding the utilization of 
EMDR and its EBT status. For example, Albright and Thyer (2010) noted, 
“evidence supporting the use of EMDR to treat combat veterans suffering from 
PTSD is sparse and equivocal, and does not rise to the threshold of labeling the 
therapy as an empirically supported treatment” (p.1). In addition, Albright and Thyer 
concluded, “There are no well-designed RCTs comparing EMDR against real-life 
exposure therapy, a treatment with a much stronger level of empirical support in the 
treatment of PTSD, or, for that matter, against credible placebo-controlled therapies” 
(p.13). Similarly, the IOM (2008) also concluded there was insufficient evidence, in 
the form of RCTs, to determine the efficacy of EMDR; however, this report is 
highly criticized (Lee & Schubert, 2009). Specifically, Lee and Schubert noted that 
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the 2008 IOM report inaccurately represented positive outcomes for EMDR, failed 
to consider a number of available studies reviewing the benefits of EMDR, and 
excluded several positive EMDR studies without explanation. Despite criticism, the 
IOM (2012) referenced their own prior findings on EMDR, and maintained their 
stance from 2008 in their latest 2012 report.   
Potential Benefits of EMDR Research With U.S. Active Military Personnel 
The VA and DOD (2010) guidelines recommend EMDR as an EBT for PTSD 
with military populations, and cite support for EMDR as an efficacious treatment for 
patients with PTSD due to a review of the existing literature. The efficacy of EMDR has 
been established in approximately 20 RCTs treating PTSD with both civilian populations 
(e.g., Lee, Gavriel, Drummond, Richards, & Greenwald, 2002; Rothbaum, Astin, & 
Marsteller, 2005; van der Kolk et al., 2007) and combat veteran populations (e.g., 
Carlson, Chemtob, Rusnack, Hedlund, & Muraoka, 1998). Furthermore, the supporting 
literature included a meta-analysis by Bisson et al. (2007), in addition to the conclusions 
arrived at by other guidelines, such as those generated by a task force for the International 
Society for Traumatic Stress Studies (ISTSS) (Spates, Koch, Cusack, Patago, & Waller, 
2009). Similarly, a meta-analysis by Maxfield and Hyer (2002) compared EMDR against 
waitlist controls, cognitive behavior therapy involving exposure, and treatment modalities 
described as other than CBT. They found the results of the EMDR trials to be superior to 
the waitlist control condition, an “overall superiority of EMDR compared to the other 
active treatment conditions” (VA & DOD, 2010, p. 129).  
EMDR therapy has a number of benefits as treatment for trauma, such as a 
limited need for self-disclosure; this is a noted benefit according to the VA and 
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DOD Clinical Practice Guidelines for the Treatment of Traumatic Stress Disorders 
(2010). The VA and DOD guidelines noted that the goal of EMDR is to ease the 
distress associated with traumatic memories through assisting patients in accessing 
and processing traumatic memories until adaptive resolution is achieved. 
Meta-analyses have studied the efficacy of EMDR and concluded that it is at least as 
efficacious in the treatment of trauma as exposure therapy and trauma-focused 
cognitive behavioral therapy (Bisson et al., 2007; Bradley et al., 2005). Furthermore, 
specific studies have highlighted that EMDR provides rapid treatment gains for 
physical presentations that make it well suited for clinical settings such as the VA 
and DOD (Russell, 2008a).  
Limitations of EMDR effectiveness research. Russell (2006), Russell et al. 
(2007), and Silver et al. (2008) were the only studies found by this literature review that 
conducted an effectiveness study of EMDR with a military population; furthermore, 
Russell (2006) and Russell et al. (2007) were the only two studies involving participants 
who were active military personnel. As noted by Bradley et al. (2005), there are 
inconsistent outcome measures utilized in all EMDR effectiveness research, and in EBT 
research in general (IOM, 2012); due to these inconsistent outcome measures, there is 
ambiguity regarding the exact improvement participants receive from treatment. Across 
the literature regarding psychotherapy for PTSD, researchers commonly note what 
percentage of participants no longer meet criteria for PTSD after treatment (Bradley et 
al., 2005); however, participants can still fall below clinical thresholds by changing or 
losing one or two symptoms while continuing to be highly symptomatic. In addition, the 
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definition of meeting PTSD is variable, depending on the specific outcome measure 
employed by researchers. 
Allegiance Effects in Research 
Luborsky, Singer, and Luborsky (1975) first coined the term therapeutic 
allegiance of the experimenter, and expressed concerns that “the therapeutic allegiance of 
the experimenter might in some way influence the results” of psychotherapy research 
(p. 1003). A number of meta-analyses of research on psychotherapy effectiveness have 
investigated the statistical relationships between the allegiances of the investigators and 
the outcomes they report, leading to concern that allegiance biased the results in favor of 
the treatment the investigator believes in (Gaffan, Tsaousis, & Kemp-Wheeler, 1995; 
Luborsky et al., 1999, 2002; Robinson, Berman, & Neimeyer, 1990). While this concern 
could be an issue in any type of psychotherapy, including RCTs, the real-world nature of 
effectiveness research indicates that the practicing clinician will typically have a strong 
belief in the therapeutic approach they are employing. This limitation was further 
substantiated through a meta-meta-analysis conducted by Munder, Brutsch, Leonhart, 
Gerger, and Barth (2013), finding robust and substantial allegiance effects across diverse 
settings of outcome research. While not necessarily feasible in most real-world settings, 
recommendations included conducting research collaboratively using teams with mixed 
allegiances, in addition to working towards ensuring that therapists in all treatment 
conditions are skilled and confident in the treatment they are delivering. At the least, it is 
suggested that effectiveness research studies consider allegiance effects as a potential 
explanation of their findings; none of the research reviewed for this study explicitly 
explored this concern.  
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Chapter III: Pilot Study on Potential Effectiveness of Implementing a PTSD-EBT 
Rationale for This Pilot Study 
Efficacy studies have emerged as the standard means of demonstrating 
through research that therapies work (Kazdin 2008, 2011). The emergence of 
efficacy studies and EBTs raises concerns as to whether or not efficacy research 
regarding how well therapies work can be generalized to actual real-world treatment 
settings (Kazdin, 2008). Given the plethora of efficacy studies on psychotherapy 
treatments for PTSD, Bradley et al. (2005) suggested publishing real-world research 
regarding the effectiveness of therapies in order to influence the practice of 
therapists. Research regarding the effectiveness of EBTs is important due to the gap 
in the literature regarding the generalizability of EBTs, including EMDR, in actual 
clinical settings with military personnel (IOM, 2012; Tanielian et al., 2008); 
specifically, few studies have examined the effectiveness of EMDR in real-world 
clinical settings, especially with military personnel and their families (IOM, 2012; 
Tanielian et al., 2008). Effectiveness studies may serve to compliment efficacy 
settings through providing evidence of the real-world generalizability of treatment 
(Bradley et al., 2005; Kazdin, 2011). To address this gap in the literature, the current 
pilot study intends to explore the potential benefits and challenges in conducting 
effectiveness research with active military personnel and their families using a 
variety of widely employed psychometric measurements.  
Methods 
Review of archival treatment data. Data from 99 archived or ‘closed’ 
treatment charts were analyzed. Of the 99 available archived cases, 49 (49.5%) came 
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from data set A, provided by the supervisor of an outpatient clinic overseas (see 
Table 8). The remaining 50 (50.5%) cases of the raw data came from data set B, 
consisting of unpublished cases provided by clinicians delivering outpatient EMDR 
therapy for military personnel or their family members in military outpatient clinics 
(Russell et al., 2007; see Table 9). The raw information provided by data set A and 
B involved no protected health information or any other personal demographical or 
clinical information. All potentially identifying client information was altered before 
treatment charts were shared in order to protect client confidentiality.  
Both data set A and set B came from the real-world setting of military 
community counseling centers. As a result of this shared setting, clinicians who 
contributed data in both sets selected EMDR treatment due to clinical factors of the 
case, and clients chose to participate in EMDR therapy. Furthermore, since clients 
had freedom to select services, many may have received other services (e.g., 
separate couples counseling, medications, etc.). No distinction was made in case 
selection regarding: gender, race/ethnicity, sexual orientation, status (e.g., military, 
civilian, retired), military rank, branch of service, presenting problem, reason for 
referral, clinical diagnosis, or number of treatment sessions, other than the required 
sample selection of charts reflecting use of EMDR therapy. In addition, all cases 
involving EMDR therapy were provided for this review, and no EMDR case was 
excluded for any reason. All of the clients processed traumatic events during their 
EMDR therapy. Given these similarities between data set A and set B, the archival 
treatment charts from both sets were joined to combine of all the available data, and 
shall henceforth be referred to, and analyzed, as a single data set (see Table 10). 
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All clients in the data set received mental health services via the military 
healthcare system. Specifically, clients received outpatient mental health care from staff 
mental health clinicians at military community mental health clinics. Due to variations in 
record keeping and limitations resulting from time constraints (e.g., instrument 
availability, patient availability, and time availability), not all clients received all of the 
pre- and post-outcome measures; given the variety of outcomes measures used 
throughout the data set, the following common measures were utilized for statistical 
analysis:  the Subjective Units of Disturbance, the Validity of Cognition Scale, the Beck 
Depression Inventory-II, the Beck Anxiety Inventory, and the PTSD Checklist-Military. 
These data were treated as a pilot study for the implementation of effectiveness research 
in real-world clinical settings; as a result, while these data include a number of 
confounding variables, the data analysis serves as a possible model for future 
effectiveness research. 
Table 8 
Pilot Study Archival Data Set A 
Active Duty 
(Total, %) 
Family Members 
(Total, %) 
Civilian Contractors 
(Total, %) 
Retired Veterans 
(Total, %) 
All Cases 
(Total, %) 
Total 37 (76%) 11 (22%) 1 (2%) 0 (0%) 49 (100%) 
Table 9 
Pilot Study Archival Data Set B 
Active Duty 
(Total, %) 
Family Members 
(Total, %) 
Civilian Contractors 
(Total, %) 
Retired Veterans 
(Total, %) 
All Cases 
(Total, %) 
Total 28 (56%) 11 (22%) 8 (16%) 3 (6%) 50 (100%) 
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Sample description. All clients were age 18 or older. There were no inclusionary 
or exclusionary criteria for the collected archival cases. Due to the archival nature of the 
data, some demographic information was unavailable at the time of this analysis. As seen 
in table 10, of the combined 99 archival cases, 65 were active-duty military personnel, 22 
were family members or spouses, nine were civilian contractors, and three were retired 
veterans. While there were a number of presenting problems among the 99 archival cases, 
PTSD was identified as the primary diagnosis for 65 (65.7%) of the clients.  
Of the archival cases diagnosed with PTSD, 42 involved combat while 23 were 
non-combat related. In addition to identified primary diagnoses of PTSD, there were two 
cases with a primary diagnosis of combat-related Acute Stress Disorder, 11 cases with a 
primary diagnosis of Adjustment Disorder, five cases with a primary diagnosis of 
Anxiety Disorder, three cases with a primary diagnosis of Major Depressive Disorder, 
two cases with a primary diagnosis of Dysthymic Disorder, and one case with 
sub-clinical PTSD symptomology. For ten out of the 99 cases, the archival data did not 
contain diagnostic information. Similarly, not all of the archival records included 
complete client demographic data. Specifically, data regarding age was available for 83% 
of the archival cases, while data regarding gender was only available for 49% of the 
cases. According to the data available from 49 cases, 63% of the participants were male. 
Of the 83% of the cases with information regarding the age of participants, the average 
age for those cases was 32.8 years old (see Table 11 for further demographical 
information). 
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Table 10 
Pilot Study Combined Patient Demographic Table 
 Active Duty Family Members Civilian Contractors Retired Veterans All Cases 
Total 65 22 9 3 99 
Age (Mean, SD) 29.1, 7.8 33, 10 42, 2.6 70, 4.9 32.8, 11.3 
Rank (Min, Max, Mean) 2, 14, 5 - - - - 
 
EMDR Treatment Sessions 
(Mean, SD) 
7.9, 6.6 6.8, 5.1 
 
3.7, 7.9 5, 3.4 7.2, 6.4 
Primary Diagnoses Combat PTSD (39) 
Non-Combat PTSD (11) 
Adjustment D/O (5) 
Anxiety (3) 
Combat ASD (2) 
Major Depressive D/O (2) 
Unknown (2) 
Sub-clinical PTSD (1) 
Non-Combat PTSD (8) 
Unknown (8) 
Adjustment D/O (3) 
Anxiety D/O (1) 
Major Depressive D/O (1) 
Dysthymia (1) 
 
Non-Combat PTSD (4) 
Adjustment D/O (3) 
Anxiety D/O (1) 
Dysthymia (1) 
Combat PTSD (3) Combat PTSD (42) 
Non-Combat PTSD (23) 
Adjustment D/O (11) 
Unknown (10) 
Anxiety (5) 
Major Depressive D/O (3) 
Combat ASD (2) 
Dysthymia (2) 
Sub-clinical PTSD (1) 
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Measurements 
Data regarding effectiveness were obtained through archival measurements from 
chart reviews, as the evaluation of client progress throughout treatment for their trauma 
was tracked according to the following psychometric measures:  
Subjective Units of Disturbance Scale. The first measure, the SUDS (Wolpe, 
1982) was originally employed by Shapiro (2001) to assess disturbances accompanying a 
remembered traumatic experience during EMDR treatment. The SUDS is a 0-10 
self-report scale where zero signifies lack of any distress and 10 represents the highest 
disturbance imaginable. Furthermore, this scale has been demonstrated to correlate with 
objective physiological indicators of stress, including pulse rate (r = .39; p < 0.05) and 
peripheral vasoconstriction (r = -.84; p < 0.01; Thyer, Papsdorf, Davis, & Vallecorsa, 
1984). The SUDS is based on face validity. Of the 99 archival cases analyzed in this pilot 
study, 98 (99%) cases contained pre- and post-outcome scores for the SUDS. 
Validity of Cognition Scale. The second measure, the VOC (Shapiro, 2001) is a 
1-to-7 Likert-type self-report scale where 1 represents a completely unbelievable 
cognition that is adaptive for the reporter, and 7 represents a cognition that is totally 
believable. It is used during EMDR treatment to assess the client’s acceptance of a new 
positive cognition, with the goal of replacing any current negative cognition. The VOC is 
based on face validity. Of the 99 archival cases analyzed, 90 (91%) cases contained 
pre- and post-outcome scores for the VOC. 
Beck Depression Inventory-II. The BDI-II (Beck, Steer, Ball, & Ranieri, 1996) 
is a 21-item self-report measure of depressive symptoms with scores ranging from zero to 
63. For the BDI-II, Beck et al. reported an internal consistency of .91 and a test-retest 
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reliability of .93. In addition, Beck at al. reported a convergent validity of .71 with the 
Hamilton Psychiatric Rating Scale for Depression. Of the 99 archival cases analyzed, 43 
(43%) cases contained pre- and post-outcome scores for the BDI-II. 
Beck Anxiety Inventory. The BAI (Beck, Epstein, Brown, & Steer, 1988) is a 
21-item self-report measure of anxiety symptoms with scores ranging from zero to 63. In 
their preliminary study of the BAI, Beck et al. reported an internal consistency of .92 and 
a test-retest reliability of .75. Also, Beck et al. reported a convergent validity of .51 with 
the Hamilton Anxiety Rating Scale. Of the 99 archival cases analyzed, 28 (28%) cases 
contained pre- and post-outcome scores for the BAI. 
PTSD Checklist – Military. The third measure, the PCL-M (Weathers, Litz, 
Herman, Huska, & Keane, 1993) is the military version of the PCL, a 17-item self-report 
measure of PTSD. Weathers et al. reported   test-retest reliability scores with Vietnam 
veterans above the recommended level of .70. In order to synthesize the results regarding 
the psychometric properties of the PCL-M, Wilkins, Lang, and Norman (2011) reviewed 
72 studies that employed the PTSD checklist. While Weathers et al. (1993) of the PCL-M 
found internal consistency scores above .80, Wilkins et al. (2011) found other studies 
reported total score values of above .75. In addition, when researching convergent 
validity, Wilkins et al. found that the PCL-M demonstrated a kappa of .64 with the PTSD 
section of the SCID with Vietnam veterans in PTSD treatment. Of the 99 archival cases 
analyzed, 22 (22%) cases contained pre- and post-outcome scores for the PCL-M. 
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Table 11 
Pilot Study Pre- and Post-Outcome Measures Table 
 
Measure  
Active Duty  
(Total, %) 
Family Members 
(Total, %) 
Civilian Contractors  
(Total, %) 
Retired Veterans 
(Total, %) 
All Cases  
(Total, %) 
SUDS  65 (100%) 21 (95%) 9 (100%) 3 (100%) 98 (99%) 
VOC 58 (89%) 21 (95%) 8 (89%) 3 (100%) 90 (91%) 
BDI-II  44 (67%) 6 (27%) 4 (44%) 3 (100%) 57 (57%) 
BAI  28 (28%) 4 (18%) 0 (0%) 0 (0%) 32 (32%) 
PCL-M  22 (22%) 2 (1%) 0 (0%) 0 (0%) 24 (24%) 
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Chapter IV: Results 
Archival clinical data was examined for the effectiveness of EMDR treatment as 
demonstrated through the pre- and post-outcome measures of the SUDS, VOC, BDI-II, 
BAI, and PCL-M.  
All SUDS Cases 
Of the 99 archival cases reviewed, 98 clients received pre- and post-outcome 
scores for SUDS. These 98 cases with SUDS scores represent the largest section of 
homogenous outcome measure data within this dataset (see Table 11). As with any 
in-session outcome measures, SUDS scores are beneficial in aiding clinicians in 
developing treatment and identifying effective treatment approaches (Smith, Fischer, 
Nordquist, Mosley, & Ledbetter, 1997). While SUDS scores alone only represent one 
measure of treatment progress, these data were analyzed in order to provide the largest 
possible sample size this study could provide across all participating demographical 
groups. 
All SUDS and VOC Cases 
In addition to the 98 cases with complete SUDS data, 90 cases also include 
pre- and post-outcome data for VOC (see Table 11). 
Active Military Cases With SUDS, VOC, and BDI-II 
In contrast to the SUDS and VOC analysis designed to capitalize on homogenous 
outcome measures, a more rigorous statistical analysis was conducted on a homogenous 
participant sample of active military participants. Of the 99 total archival cases, 43 active 
military cases were selected that contained completed SUDS, VOC, and BDI-II scores 
(see Table 11). These 43 cases involved active military participants who were seen by 
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three different therapists. Furthermore, 28 of these 43 cases, from one specific therapist, 
also included both pre- and post-outcome scores for the BAI. In addition, 22 cases from 
that same therapist also included the PCL-M scores, in addition to the SUDS, VOC, 
BDI-II, and BAI scores. 
Data Analysis Approach 
Appropriate for an effectiveness study, the initial statistical analysis of this study 
was conducted on the maximum number of cases possible, despite differences in type of 
trauma, gender, status, therapist, and setting. This analysis was conducted due to the 
external validity of this largest possible sample. These 98 cases represent the most 
diverse possible selection of this dataset with pre- and post-outcome measures, and best 
reflect the nature of trauma-focused treatment in an outpatient setting in a military 
context. In addition, another analysis was conducted in an effort to demonstrate the most 
rigorous possible analysis of the available data; specifically, the results of a smaller yet 
homogenous sample of active military personnel with more varied outcome measures 
were analyzed. 
Analysis 
In order to discuss the largest possible sample size available through these data, 
98 cases were analyzed according to their pre- and post-SUDS scores. In addition, 90 of 
these cases involved pre- and post-VOC scores, and were also analyzed. These 90 cases 
represent the most homogenous group of outcome measures within the data set.  
In contrast to the homogenous outcome measures group, there was also an 
analysis of a homogenous participant group consisting of only active military cases. 
Among the 99 available cases, there were 43 cases with active military personnel 
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receiving treatment from three different therapists who all recorded BDI-II, SUDs, and 
VOC pre- and post-outcome data; in addition, 28 cases of this subgroup also included 
pre- and post-outcome scores for the BAI, while 22 cases recorded pre- and post-outcome 
scores for the PCL-M. Since these particular 43 cases involved only active duty military 
personnel, there is increased homogeneity within this sample, compared to the 
heterogeneous nature of the entire data set of 99 archival cases. This subset of 43 cases 
was analyzed to demonstrate the most rigorous possible statistical analysis given the 
nature of these data.  
Homogenous outcome measures: SUDS and VOC analysis with all groups. 
While the archival data for these cases came from ten different therapists in different 
military community settings, a factorial ANOVA on the influence of the therapeutic 
provider variable was not conducted, as the data did not meet the assumptions for a 
factorial ANOVA. Therefore, to assess for the multivariate normality of the sample 
resulting from the use of various outcome measures, the Mahalanobis distances 
(min = .275, max = 25.515, mean = 3.956, SD = 4.359) were calculated for all 98 cases 
using a linear regression analysis (F = 9.471, p < .0005). Only one outlier was found, a 
participant for whom both SUDS and VOC scores decreased over the course of treatment. 
Such a trend indicates that for this individual, their subjective disturbance decreased 
throughout treatment, but so did the validity of their replacement cognition. Since a 
multivariate analysis of variance (MANOVA) is able to tolerate a few outliers (Pallant, 
2007), data from this participant was included in the overall analysis, as this was 
determined to best reflect the effectiveness goals of this pilot study. Pre- and 
post-treatment outcome scores were used as covariates. As a result, given the 
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demonstrated multivariate normality of the data, the covariance was analyzed for the 
cases with 98 pre- and post-SUDS scores as well as the 90 pre- and post-VOC scores. 
The resulting MANOVA of pre- and post-outcome scores for SUDS and VOC 
generated a significant Wilks' Lambda (F (2, 88) = 501.880, p < .0005, Λ = .080, 
η2 = .92), indicating a significant difference between the dependent variables of SUDS 
and VOC. Given this significant difference, it was determined that the SUDS and VOC 
assessed different variances within subjects, and could therefore be separately analyzed. 
As a result, the SUDS (n = 98) and VOC (n = 90) were both analyzed utilizing paired 
t-tests and presented in Table 12. The improvements in SUDS scores were significant 
across all 98 cases (t(97) = 28.720, p < 0.0001); similarly, the VOC scores of all 90 
participants also made significant increases (t(89) = - 18.215, p < 0.0001). These 
significant improvements in both the SUDS and VOC scores indicate that the disturbance 
associated with the targeted traumatic memories of the participants had been largely 
eliminated, and that a new, more positive perception of the memories had developed. 
Table 12 
Pilot Study SUDS and VOC Results Table 
Measure  Pre-treatment 
 Mean, (SD) 
Post-treatment 
Mean, (SD) 
 Improvement After 
Treatment Mean 
p 
 SUDS (n = 98)  7.64, (2.012) 0.87, (1.476)  6.78 < 0.0001 
 VOC (n = 90)  3.21, (1.963) 6.92, (0.269)  3.71 < 0.0001 
Homogenous participant analysis: BDI-II, BAI, and PCL-M analysis for 
active military personnel. As these cases were assessed using a variety of treatment 
measures (SUDS, VOC, BDI-II, BAI, and PCL-M), it was again necessary to determine 
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the multivariate normality of the sample. To assess for the multivariate normality of these 
cases, the Mahalanobis distances (min = 2.232, max = 13.892, mean = 5.714, 
SD = 3.461) were calculated for these cases using a linear regression analysis (F = 2.663, 
p < .061), and no outliers were found. Furthermore, since these cases came from three 
different therapists, it was necessary to eliminate the therapist differences as a potential 
influencing factor regarding treatment outcome. Therefore, these 43 cases were analyzed 
using a factorial ANOVA (F(2, 40) = 1.387, p < .262, Λ = .935, η2 = .065). No 
significant interaction was found between providers and treatment. Since there was no 
significant interaction resulting from therapist interaction, therapist effects were not 
considered as an independent variable. 
In addition, of the 43 active military service member cases with BDI-II data, 28 of 
these cases from one therapist also included both pre- and post-outcome scores for the 
BAI. Furthermore, 22 cases from that same therapist also included the PCL-M. In order 
to ensure that dependent t-tests on the BDI-II, BAI, and PCL-M variables would not 
analyze the same variance, these 43 cases were analyzed using a MANOVA 
(F(3, 18) = 26.790, p < .0005, Λ = .183, η2 = .817). These results indicate that there are 
significant differences among the groups of BDI-II, BAI, and PCL-M scores; as a result, 
all 43, and the three different outcome measures, cases were all analyzed separately using 
dependent t-tests. 
Therefore, the pre- and post-treatment scores from the outcome measures of 
BDI-II (n = 43), BAI (n = 28), and PCL-M (n = 22) were all analyzed utilizing paired 
t-tests as presented in Table 13. Among the active military service member participants, 
the improvements in BDI-II scores from after EMDR treatment were significantly 
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improved across all 43 cases (t(42) = 9.586, p < 0.0001). For the same population, BAI 
scores also improved significantly after EMDR treatment for all 28 participants 
(t(27) = 4.551, p < 0.0001); in addition, scores on the PCL-M after EMDR treatment of 
active military service members (n = 22) similarly demonstrated a significant 
improvement (t(21) = 9.135, p < 0.0001). 
Table 13 
Pilot Study Active Military BDI-II, BAI, and PCL-M Results Table 
Measure  Pre-Treatment 
 Mean, (SD) 
 Post-Treatment 
 Mean, (SD) 
 Improvement After 
Treatment Mean 
p 
 BDI-II (n = 43)  25.35, (10.488)  6.51, (7.052)  18.84  
(on a scale of 0-63) 
< 0.0001 
 BAI (n = 28)  22.93, (14.877)  8.21, (8.591)  14.72 
(on a scale of 0-63) 
< 0.0001 
 PCL-M (n = 22)  55.55, (15.417)  27.82, (10.595)  27.73 
(on a scale from 17-85) 
< 0.0001 
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Chapter V: Discussion 
The primary goal of the current pilot study was to illustrate the value of 
effectiveness research for military populations; in doing so, the results also highlighted 
the relative ease and benefits of tracking treatment progress. Following the 
recommendations of both the IOM (2012) and Tanielian et al. (2008), data was gathered 
regarding the effectiveness of an EBT PTSD intervention in a military setting. Tanielian 
et al. (2008) reported a dearth of available information regarding the quality of mental 
health care provided in military settings. Specifically, the lack of routine and consistent 
outcome measures was cited as a primary cause for this gap in quality assessment 
(Tanielian et al., 2008, p. 300). Relatedly, Bradley et al. (2005) recommended that 
effectiveness research be conducted as a method of demonstrating how EBTs perform in 
the community (p. 226); although, while the VA and DOD (2010), IOM (2012), 
Tanielian et al. (2008), and Bradley et al. (2005) recommended further effectiveness 
research regarding the clinical utility of EBTs, there is a contradiction in that none of 
these authors review effectiveness research in their publications. 
The current pilot study addresses these gaps in the literature through the analysis 
of an EBT as utilized with military populations in a military community setting. 
Treatment outcome measures employed in this pilot study were the most commonly used 
outcome measures found through a literature review of the both efficacy and 
effectiveness research published since the release of the VA and DOD guidelines (2004, 
2010). As a result, the potential implications of employing EBTs and tracking treatment 
progress in real-world settings were demonstrated. Through the utilization of commonly 
employed outcome measures, significant improvements in PTSD symptomology were 
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found; thereby illustrating the effectiveness of an EBT in treating active military 
personnel, their family members, veterans, and civilian contractors in a real-world 
setting.  
Before exploring the potential implications of these results, it is necessary to 
acknowledge the limitations of the current pilot study. As an effectiveness study of an 
EBT, this study was subject to all of the common limitations of outcome research. These 
limits include: a lack of treatment outcome data from all the archival data of all cases; an 
inability to ensure the sample used was random and representative of all treated patients; 
and an absence of comparison treatment. In addition, archival case data was gathered 
only from volunteer clinicians who functioned in diverse environments with differing 
resources. Allegiance effects should also be taken into consideration, as the treating 
clinicians all believed in their choice of treatment. Furthermore, there was no control 
group, and there were no independent raters of the treating clinicians.  As acknowledged 
at the beginning of this project, these factors prevent the findings from being considered 
definitive efficacy research regarding EMDR; however, they do not prevent the results 
from contributing to effectiveness research on EMDR and PTSD EBTs in general 
(Bradley et al., 2005; Tanielian et al., 2008). 
The potential effectiveness of an EBT, specifically EMDR, in treating a 
variety of mental health disorders in a military community setting was demonstrated. 
A primary criticism of RCTs conducted with EBTs is the lack of generalizability to 
practical clinical settings (Chambless & Hollon, 1998; Kazdin, 2008; Seligman, 
1995). One frequently cited cause of the lack of generalizability of RCT results is 
participant screening due to exclusionary and inclusionary criteria that usually 
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eliminates comorbid concerns frequently encountered in the real world (Chambless 
& Hollon, 1998; Kazdin, 2008, 2011; Seligman, 1995). As the current pilot study 
was designed as effectiveness research, no research-based exclusionary or 
inclusionary criteria were established; therefore, through the inclusion of all 
participants, these results demonstrated the generalizability and applicability of an 
EBT, specifically in a military community setting with active military personnel, 
their families, civilian contractors, and veterans.  
While the topic is rarely discussed in the literature, it should be noted that all 
therapeutic modalities, including EMDR, have implicit and explicit inclusionary and 
exclusionary criteria. For example, when reviewing the appropriateness of EMDR 
therapy for a particular client, clinicians employ a screening for Dissociative 
Disorder (Shapiro, 2001); special preparation for clients with Dissociative Disorder 
is necessary, and in some cases, EMDR may not be advisable with those individuals. 
Furthermore, other criteria are considered, such as: life threatening substance abuse, 
serious suicide attempts, self-mutilation, inadequate social support, medical 
conditions, and neurological impairment (Shapiro, 2001). Similarly, exclusionary 
and inclusionary criteria exist for all treatment modalities. In effectiveness research, 
therapists and clients both must agree on a particular therapy before beginning 
treatment. While the effectiveness research is not imposing additional inclusionary 
or exclusionary criteria, both implicit and explicit criteria exist as part of the 
modality selection by therapist and client. Therefore, while it may not be discussed 
in the research literature, all effectiveness research will inherently include 
exclusionary and inclusionary criteria; as a result, this concern should be kept in 
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mind when reviewing research literature. 
Of the 99 archival cases reviewed, the majority (n = 65) were active military 
personnel. Similarly, the most common diagnoses were combat-related PTSD 
(n = 42) and non-combat related PTSD (n = 23). Across all outcome measures 
utilized (SUDS, VOC, BDI-II, BAI, and PCL-M), the results after treatment 
indicated significant improvement (p < 0.0001). The results demonstrated how 
common in-session outcome measures can serve to aid clinicians in identifying the 
effectiveness of their treatment approaches, as highlighted by Smith et al. (1997). In 
service of recommendations made by the IOM (2012) and Tanielian et al. (2008), 
the outcome measures utilized for this pilot study provide a common, consistent, and 
approachable method for tracking treatment progress in addition to beginning the 
process of illustrating the long-term effectiveness of EBTs.  
Tracking Treatment Outcomes 
As reported by both the IOM (2012) as well as Tanielian et al. (2008), the VA and 
DOD lack a formalized methodology for tracking treatment progress; therefore key 
treatment questions remain unanswered. Specifically, the IOM (2012) suggested that the 
lack of effectiveness research from the VA and DOD demonstrates a barrier in accessing 
mental health care for military personnel, as this lack impedes the “translation of research 
findings into practice” (p. 341). Furthermore, the IOM noted that the VA and DOD 
needed to address concerns about the generalization of research with other populations 
and settings into treatment for military personnel in military settings. The VA and DOD 
are in a unique position to examine which veterans are pursuing treatment and what types 
of treatment those veterans are receiving (IOM, 2012, p. 364; Tanielian et al., 2008, 
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p. 290); as a result, outcome measures might provide valuable information regarding if
and how veterans are benefiting from treatment. The IOM (2012) also recommended that 
EBTs for PTSD should be provided to military personnel as quickly possible, and that 
progress should assessed throughout treatment. Results from the tracking of treatment 
outcomes should inform the appropriateness of long-term treatment. This pilot study 
provides a potential model for the tracking of EBT treatment of PTSD through the use of 
outcome measures commonly utilized across the literature; the results illustrated the 
significant impact of an EBT intervention for PTSD and other diagnoses with military 
personnel and their families.   
A Potential Effectiveness Research Model 
The current pilot study presents a potential or partial model for effectiveness 
research, highlighting the benefits of research conducted in real-world settings despite the 
confounding and complicating variables. Particular attention should be given to the 
benefits for military and their families resulting from addressing the long-term 
consequences of trauma-related disorders, as the untreated symptoms of trauma can 
negatively impact veterans, their families, and their communities (IOM, 2012; Tanielian 
et al., 2008). Furthermore, veterans, the military, and society at large can benefit from 
early intervention, as it might aid veterans in either continuing their military career or 
pursuing other career opportunities with fewer disruptions (IOM, 2012; Russell et al., 
2007; Tanielian et al., 2008).  
The framework for the current study was the demonstration of a feasible means 
for researching already-established EBTs. Given that the VA and DOD (2010) guidelines 
clearly endorsed four well-researched and efficacious therapeutic approaches, this study 
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focused on the potential benefit of implementing EBTs, especially in the treatment of 
trauma and combat-related PTSD. The result provides a potential or partial model for 
clinicians to implement EBTs, such as those recommended by the VA and DOD 
guidelines (2010), track their effectiveness in community settings, and contribute to the 
understandings of the field. 
These results are an example of how clinicians can, with relative ease, monitor 
results in the real-world settings, track therapeutic change, and review treatment results; 
however, inconsistent outcome measure across archival data presented a limitation. 
Similarly, while the current study lacked the internal validity of a rigorous efficacy study, 
it demonstrated the viability of effectiveness research through analysis of several 
common outcome measures. Given the dearth of outcome research (Bradley et al., 2005; 
Tanielian et al., 2008), particularly with the vulnerable population of recently returned 
from overseas veterans, these results represents a feasible method for how therapists can 
track outcomes. Future studies could improve on this model through improved record 
keeping, including demographic characteristics of participants, and the consistent use of 
common outcome measures. In this way, clinicians in the field can operate as researchers 
and collect data utilizing relatively unobtrusive self-report measures, and thereby 
contribute towards the overall advancement of the field. For example, all of the measures 
utilized in this research were self-report, and took relatively little time for client and 
therapist to complete. 
Potential allegiance effects. While Munder et al. (2013) reported that allegiance 
effects might explain the findings of effectiveness research, similar concerns could be 
voiced regarding the impact of researcher belief on the results in efficacy studies. As 
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Luborsky et al. (1975) noted, the therapeutic alliance of any researcher could influence 
results; as a result, any therapeutic alliance between researcher or clinician and 
participant or client must be taken into consideration. Munder et al. (2013) provided 
recommendations that may control allegiance effects; however, those recommendations 
may not be feasible in most real-world settings. Furthermore, these recommendations 
may introduce obstacles, financial or methodological, that make effectiveness research 
unattainable.   
Developing Standards for Effectiveness Research 
Instead, the field may benefit from the introduction of standards for effectiveness 
research. While many criteria do not apply, some of the standards from the Platinum 
Standard of efficacy research established Hertlein and Ricci (2004) are relevant to 
effectiveness research, and could serve as a starting point. Of greatest benefit are 
Platinum Standards one and two: clearly defined target symptoms, and reliable and valid 
measures. Platinum Standards three is not applicable to real-world settings, as a blind and 
independent assessor is not typically available or practical, and therefore Platinum 
Standard four regarding assessor reliability is also not a concern. The fifth Platinum 
Standard, regarding manualized treatment, does not accurately capture the flexibility of 
real-world treatment. While a clinician may be using a manualized treatment as part of 
psychotherapy, the situation may call for a change in treatment technique or therapeutic 
approach; as a result, while this Standard may be utilized in some effectiveness research, 
it cannot be a requirement. Due to client and therapist choice of therapy in the real world, 
the random assignment as recommended by Platinum Standard six does not apply. 
Platinum Standard seven, treatment adherence, would require fidelity assessment, and is 
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therefore impractical in most real-world settings. Similarly, Platinum Standard eight 
regarding non-confounding conditions, is an uncontrollable factor in a typical clinical 
settings. In contrast, Platinum Standards nine and ten, the use of multimodal measures 
and the length of treatment, are both factors that can be taken into consideration during 
effectiveness research. Platinum Standard 11, reported level of therapist(s) training, is 
highly relevant to effectiveness research; however, Platinum Standard 12, use of a 
comparison or control group, does not apply to effectiveness research. Finally, Platinum 
Standard 13, effect size reporting, is not necessarily relevant to effectiveness research as 
there is no control group. 
 Therefore, proposed effectiveness standards can be based upon efficacy Hertlein 
and Ricci’s (2004) Platinum Standards one, two, nine, ten and 11: clearly defined target 
symptoms; reliable and valid measures; the use of multimodal measures; the length of 
treatment; and the level of therapist training. The inclusion of clearly defined target 
symptoms is an element of good clinical practice, and can be enhanced through the 
inclusion of a treatment plan and diagnosis if applicable. Relatedly, the utilization of 
reliable and valid measures, be they self-report or otherwise, allows for the collection of 
data outside of clinical interviews and observations. Ideally, there would be standards 
established in the field regarding the assessment of various disorders. To this end, the 
American Psychiatric Association (2014) published online assessment measures that 
compliment disorders as established in the Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5); the widespread utilization of assessment measures 
such as the Severity of Posttraumatic Stress Symptoms measure could lead to 
standardization of outcome measures. Furthermore, the inclusion of multimodal 
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measures, such as the use of self-report measures in addition to behavioral measures or 
interview, adds additional data points for analysis in effectiveness research. While the 
length of treatment is highly variable depending on the therapeutic goals and type of 
psychotherapy, tracking such information is undoubtedly beneficial to the research and 
assessment of psychotherapy effectiveness. In addition, the level of therapist training 
provide context for the therapeutic intervention, and can be used to validate therapist 
competency. 
In some treatment settings there may be utility for Platinum Standards five and 
seven: manualized, replicable, specific treatment, and treatment adherence; although, it 
may be the case that many real-world treatment settings will not specifically adhere to a 
manualized treatment consistently for the duration of treatment. Rather, due to any 
number of comorbid or confounding concerns, psychotherapy will respond to relevant 
presenting concerns and crises. This flexibility of treatment, sometimes in response to the 
inclusion of comorbid or confounding concerns, emphasizes the external validity of 
effectiveness research. 
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Table 14 
Proposed Effectiveness Research Study Standards 
Clear Standards 
Standard 1: Clearly defined target symptoms 
Standard 2: Reliable and valid measures 
Standard 3: The use of multimodal measures 
Standard 4: The length of treatment 
Standard 5: The level of therapist training 
Potential Standards 
Standard 6: Manualized, replicable, and specific treatment 
Standard 7: Treatment adherence 
Note. Adapted from “A systematic research synthesis of EMDR studies: Implementation 
of the Platinum Standard,” by K. M. Hertlein and R. J. Ricci, 2004, Trauma, Violence, & 
Abuse, 5(3), pp. 288-289. Copyright 2004 by Sage Publications. Adapted with 
permission. 
Future Directions 
The results of this study suggest that more effectiveness studies of EBTs, 
including EMDR, involving early intervention and long-term follow-up, would benefit 
VA and DOD clinicians by providing comparative information to assist in the selection 
of appropriate treatment. The VA and DOD (2010) guidelines concluded that early 
intervention is critical to prevent long-term disability, and the substantial occupational 
risks and long-term costs for veterans have been established (Russell et al., 2007). 
Similarly, Tanielian et al. (2008) found that active military personnel and veterans 
reported PTSD, depression, and anxiety symptoms interfered with their ability to 
transition back from combat situations. This pilot study represents a potential model for 
assessing the effectiveness of EBTs as used in community settings; however, due to the 
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lack of long-term follow-up data, it does not serve to demonstrate the long-term 
effectiveness of EBTs in treating trauma as recommended by the IOM (2012) and 
Tanielian et al. (2008). Furthermore, without consistent or agreed upon outcome 
measures throughout effectiveness research, it is unclear how clinicians can compare 
studies or ascertain the effectiveness of EBTs (IOM, 2012). Similarly, discussion of the 
inclusionary and exclusionary criteria inherent to different therapeutic modalities may 
benefit clinicians in assessing the appropriateness of different EBTs with various 
populations.   
As a result, it is recommended that future research should be conducted on the 
long-term effectiveness of EBTs in the treatment of trauma with military populations. 
Long-term effectiveness research studies should include detailed follow-up of military 
personnel, particularly with individuals who exhibited combat-related PTSD. This 
population may encounter different adjustment issues that may be more intense or 
complicated as a result of their usually multiple and complex war traumas. Given the 
results of this study, as well as others, it is in the interest of the DOD to formally facilitate 
or conduct related research. 
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